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Advances  in  cell  culture  methods,  multidisciplinary  research,  clinical  need  to  replace  lost skin  tissues
and  regulatory  need  to replace  animal  models  with  alternative  test  methods  has  led to development  of
three  dimensional  models  of  human  skin.  In  general,  these  in  vitro  models  of  skin  consist  of  keratinocytes
cultured  over  ﬁbroblast-populated  dermal  matrices.  Accumulating  evidences  indicate  that  mesenchyme-
derived  signals  are  essential  for  epidermal  morphogenesis,  homeostasis  and  differentiation.  Various
studies show  that  ﬁbroblasts  isolated  from  different  tissues  in the  body  are  dynamic  in nature  and  are
morphologically  and  functionally  heterogeneous  subpopulations.  Further,  these  differences  seem  to be
dictated  by the  local  biological  and  physical  microenvironment  the  ﬁbroblasts  reside  resulting  in  “posi-
tional  identity  or memory”.  Furthermore,  the  heterogeneity  among  the  ﬁbroblasts  play  a  critical  role  inkin substitutes
issue engineering
scarless  wound  healing  and  complete  restoration  of  native  tissue  architecture  in fetus  and  oral  mucosa;
and excessive  scar  formation  in  diseased  states  like  keloids  and  hypertrophic  scars.  In  this review,  we
summarize  current  concepts  about  the  heterogeneity  among  ﬁbroblasts  and  their role  in  various  wound
healing  environments.  Further,  we  contemplate  how  the  insights  on ﬁbroblast  heterogeneity  could  be
applied  for the  development  of next  generation  organotypic  skin  models.
©  2015  The  Authors.  Published  by  Elsevier  GmbH.  This  is an  open  access  article  under  the CC
BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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. Introduction
Skin is the largest organ in the human body that consists of
ightly organized layers of keratinocytes and the underlying der-
is. The skin is highly specialized in terms of providing barrier
unction by preventing water loss, resisting mechanical trauma,
rotection against physical, chemical and/or biological agents such
s temperature, light, metals, chemicals, toxins, micro-organisms
fungi, bacteria, viruses) (Simpson et al., 2011). In addition to the
arrier function, the skin plays a role in sensation, thermoregu-
ation, excretion, absorption, pigmentation and innate/acquired
mmunity. In addition, the skin has very complex appendages,
uch as hair follicles, sebaceous glands, sweat glands and nails.
ecapitulating the skin with such complex functionalities in-vitro
s a daunting task that requires the need for a complex three-
imensional (3D) microenvironment that cannot be provided by
onventional monolayer cultures. Advances in cell culture meth-
ds, multidisciplinary research, clinical need to replace lost skin
issues and regulatory need to replace animal models with alter-
ative test methods has led to development of 3D organotypic
odels of human skin consisting primarily of keratinocytes over
broblasts-populated dermal matrices. The need for these organ-
typic models of skin are immense and have profound implications
ot only for basic scientists and tissue engineers, but also for cli-
icians, manufacturers, regulatory authorities and animal welfare
rganizations. Thus it is imperative that we understand how nor-
al  skin develops, is regulated, and heals during recovery from
ounding. What we now know is that ﬁbroblasts are an integral
art of mesenchyme-derived signals that are essential for epider-
al  morphogenesis, homeostasis and differentiation.
Fibroblasts are the most abundant cell type within all the body’s
onnective tissues, and their primary role is secretion of the compo-
ents of the extracellular matrix (ECM). In the case of the skin, the
pidermal keratinocyte layer is underpinned and intimately con-
ected to the dermis, which contains the dermal ﬁbroblasts as well
s immune cells, blood vessels, nerve ﬁbers, hair follicles and secre-
ory glands. Early attempts to model the human skin in vitro used
onolayer cultures of keratinocytes and/or ﬁbroblasts, and while
hese studies formed the foundation of our current knowledge, they
ere unsuitable for studying the interaction between the two cell
ypes as they were unable to take into account the effect of spa-
ial organization of the skin layers. In addition, they do not have
 corneal layer and a differentiated epidermis with the variety of
roperties of the keratinocytes in different differentiation stages.
dvances in culturing techniques have since led to the development
f organotypic culture systems that mimic  the 3D organization of
eratinocytes and ﬁbroblasts observed in vivo (Auxenfans et al.,
009). Keratinocytes are seeded onto ﬁbroblast-populated dermal
atrices then cultured at the air–liquid interface to drive epidermal
ifferentiation, stratiﬁcation and corniﬁcation, which results in an
ngineered skin tissue that closely mimics the native skin (Bell et al.,
981; Boehnke et al., 2007; Butler et al., 2008; Cario-Andre et al.,
006; Chen et al., 1995; El Ghalbzouri et al., 2002a,b, 2005; Lamb
nd Ambler, 2013; Liu et al., 2007; Mufﬂer et al., 2008; Ponec et al., .  .  .  .  . . . .  . .  .  . . . . . .  .  . . . . . .  . . . . .  . . .  . . . .  . . .  . . . . .  . . . .  .  . . . .  . .  . . .  .  .  .  . . .  .  .  . . . . . .  . . .  505
1997, 2001; Pontiggia et al., 2013; Smola et al., 1994; Stark et al.,
1999, 2004a,b, 2006). These engineered skin mimics have success-
fully been used to study various aspects of skin biology including
epithelial-mesenchymal interactions (Maas-Szabowski et al., 1999;
Smola et al., 1993, 1994), growth and differentiation of keratino-
cytes (Boukamp et al., 1990; Maas-Szabowski et al., 2000; Mufﬂer
et al., 2008; Stark et al., 2004b, 2006), development of epithelial bar-
rier properties (Pasonen-Seppanen et al., 2001; Ponec et al., 1997,
2001; Regnier et al., 1993; Thakoersing et al., 2012), dynamics of the
basement membrane (Breitkreutz et al., 1997, 2004; El Ghalbzouri
et al., 2005; Fleischmajer et al., 1998; Nischt et al., 2007; Smola
et al., 1998; Stark et al., 2004b), wound healing (Boyce and Warden,
2002; Geer et al., 2002; Harrison et al., 2006; Laplante et al., 2001)
and dermatopathology (Barker et al., 2004; Butler et al., 2008; Chiu
et al., 2005; Eves et al., 2000). They have also revealed new and
intriguing properties of the dermal ﬁbroblast population with pro-
found implications for our understanding of how the skin works
and how we might be able to engineer optimal skin substitutes for
industrial and clinical use.
In this review we will discuss current knowledge and recent
breakthroughs in our understanding of ﬁbroblasts, with particu-
lar reference to the dermal ﬁbroblast population and its effects on
human skin development, homeostasis and healing. We  will look
at how knowledge gained from in vivo wound healing studies and
scarring phenotypes can be combined with the latest insights from
reconstituted skin models to inform the next steps in development
of biological skin substitutes. Finally, we  will highlight several ques-
tions in the ﬁeld and consider how the next generation of in vitro
models might be optimized to ﬁnd the answers and facilitate devel-
opment of clinically-appropriate skin replacements.
2. Fibroblasts in the skin
Conventionally, ﬁbroblasts are deﬁned by their spindle-shaped
morphology, adhesive growth on tissue culture plastics, expres-
sion of mesenchymal markers that include vimentin and collagen
I, and the lack of expression of markers related to other speciﬁc
cell lineages. While traditionally considered a static population of
spindle-shaped cells that maintain and support the skin through
secretion and degradation of ECM, we now know that ﬁbroblasts
play an important role in almost every skin process throughout life:
in the embryo, ﬁbroblasts direct skin morphogenesis; in the mature
organism they contribute to homeostasis of the skin; and their
involvement in various physiopathological conditions including
healing, ﬁbrosis, aging, psoriasis, and skin cancer, is just beginning
to be understood. The dermal ﬁbroblast population also under-
takes dynamic and reciprocal interactions with other resident cell
types (epithelial cells, endothelial cells, neural cells, adipocytes,
inﬂammatory cells, and resident stem cells) through direct cell–cell
communications, cell–matrix interactions, and the secretion of sol-
uble factors (growth factors and cytokines) (Borchers et al., 1994;
Costea et al., 2003; Eming et al., 2007; Maas-Szabowski et al., 1999;
al of C
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ueller and Fusenig, 2002; Werner et al., 1992, 2007; Werner and
mola, 2001).
Recent studies have also shown that the ﬁbroblasts of the skin
xist as morphologically- and functionally- heterogeneous subpop-
lations: the ﬁbroblast population within the superﬁcial layers of
he dermis (the papillary dermis) is physiologically distinct from
hat residing in deeper layers (the reticular dermis), and differ-
nt again is the population associated with hair follicles (follicular
ermal papilla (FDP) and dermal sheath (DS) ﬁbroblasts) (Chuong
t al., 2007; Harper and Grove, 1979; Honardoust et al., 2012a,b;
ahoda and Reynolds, 2001; Ohyama et al., 2010; Schafer et al.,
985; Sorrell et al., 2004, 2008). Advances in molecular techniques
ave begun to shed light on the precise nature of ﬁbroblast hetero-
eneity, revealing that despite their common phenotype, dermal
broblast subpopulations exhibit distinct gene expression patterns
nd variable functions (Chang et al., 2002; Fries et al., 1994; Rinn
t al., 2006).
.1. Fibroblast diversity
The ﬁbroblast population of the adult body exhibits functional
iversity that is generated on several levels, beginning with the
mbryonic origin of the population, then by the tissue and microen-
ironment of residence.
.1.1. The embryonic origin of ﬁbroblasts
Fibroblasts in different parts of the body arise from different
mbryonic origins; while those in the face are generated from the
eural crest, dorsal skin from the dermato-myotome, and ventral
kin comes from the lateral plate mesoderm (Houzelstein et al.,
000; Le Lievre and Le Douarin, 1975; Ohtola et al., 2008; Wong
t al., 2006) (Fig. 1). Recently, two elegant studies in mice have
dentiﬁed distinct population of dermal ﬁbroblasts during devel-
pment and in the adult skin. Using lineage tracing studies in mice,
riskell et al. (2013) identiﬁed that dermal ﬁbroblasts arise from
 multipotent progenitor population that expresses PDGFR˛, Dlk1
nd Lrig1; which upon differentiation gives rise to all the dermal
broblast lineages. During early development, PDGFR˛, Lrig1, and
limp1 expressing subpopulations give rise to ﬁbroblasts of the
apillary dermis; while PDGFR˛, Dlk1 and Sca1 expressing subpo-
ulation gives rise to reticular and hypodermal ﬁbroblast lineages.
urther differentiation and fate restriction of these subpopula-
ions give rise to the different ﬁbroblast subsets of the papillary,
eticular and hypodermis. Similarly, Rinkevich et al. identiﬁed the
xistence of two distinct embryonic ﬁbroblast (Engrailed-1 (En1)-
ositive and negative) lineages, the embryonic expression of En1
eing responsible for the deposition of the bulk of dermal con-
ective tissue during embryonic development, cutaneous wound
ealing, radiation-associated ﬁbrosis and cancer stroma (Rinkevich
t al., 2015). Further they demonstrated that the ﬁbrogenic ﬁbro-
last lineage could be identiﬁed by its expression of CD26/DPP4;
nd small molecule-based inhibition of DPP4 enzymatic activity
uring wound healing was associated with diminished scarring.
owever, the relevance of these ﬁndings to development of human
kin needs to be validated.
Alongside the embryonic origin of developing ﬁbroblast popu-
ations, their spatial organization within the embryo drives pattern
ormation, gives important positional information, and ultimately
esults in formation of tissues and organ systems. These spatial
atterns and positional information underlies cellular specializa-
ion and therefore has to be maintained throughout the life span
f the living being as the tissues undergo renewal, repair and
egeneration. This is well-illustrated in the skin: selective dis-
ribution of body hair and sweat glands is a classic example of
patial specialization; similarly, many dermatological conditions
for instance, acne and keloids) are much more likely to occur atell Biology 94 (2015) 483–512 485
speciﬁc anatomic sites. Intriguingly, it appears that much of the spa-
tial specialization seen in the skin is in fact driven by the underlying
dermal ﬁbroblasts. Early heterotopic recombination studies using
dermal and epidermal explants ﬁrst suggested the deterministic
role of dermal tissues upon the epidermis, in particular in deﬁning
positional identity during embryogenesis (Malacinski and Bryant,
1984). This was  initially indicated by experiments where dental
epithelium derived from chick embryos was cultured upon dermal
mesenchyme which drove development of a complete skin epider-
mis  with appendages; accordingly, dental mesenchyme directed
the differentiation of skin epidermis towards formation of a dental
organ (Kollar, 1986). Similarly, recombination of wing epithelium
with leg mesenchyme results in the generation of scales instead
of feathers (Dhouailly et al., 1978). Extending these observations
using in vitro skin equivalent models found that human dermal
ﬁbroblasts derived from palmoplantar sites induce keratinocytes of
non-palmoplantar origin to form an epidermis with hyperkeratosis
and keratin-9 expression reminiscent of an in vivo palmoplantar
epidermal phenotype (Yamaguchi et al., 1999). Taken together,
such heterotopic recombinant studies elegantly reveal the instruc-
tive role of mesenchymal tissues towards their overlying epithelia,
which is crucial during skin development, repair and disease.
2.1.2. Anatomic heterogeneity among ﬁbroblasts
Even within ﬁbroblast populations that share a common embry-
onic origin considerable diversity exists as a product of distinct
anatomic locations and their associated microenvironments. As
early as the 1960’s, it was known that ﬁbroblasts derived from
skin, mesothelium, joints or periosteum exhibited detectable dif-
ferences in metabolic activity (Castor et al., 1962). In the case
of the skin, dermal papillary ﬁbroblasts from hair-bearing areas
interact with follicular epithelial cells to induce hair formation,
while dermis from the glabrous skin of palms and soles instructs
for alternative epithelial fates (Kishimoto et al., 1999). Moreover,
such ﬁbroblasts derived from glabrous skin are smaller, are more
proliferative, and express lower levels of transforming growth
factor-1 (TGF1)-receptor II, -smooth muscle actin (-SMA) and
ﬁbronectin compared to ﬁbroblasts from non-glabrous skin (Chipev
and Simon, 2002).
Molecular interrogation of ﬁbroblast populations from various
anatomic sites has added another dimension to our appreciation
of ﬁbroblast heterogeneity and complexity. Genome-wide gene
expression proﬁling studies of primary ﬁbroblasts from differ-
ent anatomical sites in fetal and adult humans have uncovered
site-speciﬁc differences in gene expression proﬁles relating to pat-
terning and positional information based on anterior-posterior,
proximal-distal and dermal-nondermal anatomic divisions (Chang
et al., 2002; Rinn et al., 2006). These studies found marked topo-
graphic differences in expression of genes related to growth and
differentiation, ECM production, cell migration, lipid metabolism
and various genodermatoses. Interestingly, it now seems that topo-
graphic heterogeneity is manifested in the context of retained
embryonic gene expression patterns; comparison of fetal and adult
human ﬁbroblasts revealed ongoing expression of key HOX genes,
which direct the development of the embryonic body plan, in adult
ﬁbroblasts (Rinn et al., 2006), indicating that the HOX family of
transcription factors may  continue to provide positional informa-
tion throughout the adult life of ﬁbroblasts. Further studies will
be required to link the observed differences in gene expression
between various ﬁbroblast sub-populations and the underlying
mechanisms that determine ﬁbroblast phenotype and function.
Understanding the molecular regulation of ﬁbroblasts between and
within speciﬁc anatomic sites will open the door for development
of tailored skin substitutes both for research and clinical use in
patients requiring reconstruction in those regions.
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Fig. 1. Schematic model depicting the developmental heterogeneity in the origin of dermal ﬁbroblasts based on studies in humans and mice. Fibroblast progenitors arise
from  different developmental origins like neural crest, lateral plate mesoderm and dermatomyotome depending on the site of skin. These site-speciﬁc ﬁbroblast progenitors
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lso  suggest that papillary dermal ﬁbroblasts upon aging might differentiate to reti
.1.3. Heterogeneity within the dermal ﬁbroblast compartment
Besides the differences among ﬁbroblasts from different parts
f the body, the ﬁbroblasts within a single tissue like the skin are
ikewise not composed of a homogeneous population. Studies sug-
est the existence of anatomic subsets of dermal ﬁbroblasts that are
eﬁned by their location within the dermis: ﬁbroblasts that exist
ithin the papillary dermis, the reticular dermis, and in associa-
ion with hair follicles (FDP and DS ﬁbroblasts) (Cormack, 1987;
orrell and Caplan, 2004) (Fig. 2). Papillary dermis is the superﬁcial
ortion of the dermis that lies immediately beneath the epidermis
nd contains the rete ridges, those projections of the epidermis
hat serve to increase the surface area for interactions between the
pidermal and dermal layers. The papillary dermis is demarcated
rom the underlying reticular dermis by a vascular plexus, the rete
ubpapillare: between this superﬁcial vascular plexus and the deep
ascular plexus (rete cutaneum) is the reticular dermis, and below
ests the hypodermis. Hair follicles and their associated dermal cells
re most often found in the hypodermis, while the papillary dermis
s the thinnest, most vascular and most innervated region within
he dermis.
Various studies have demonstrated that papillary and retic-
lar dermal ﬁbroblasts are morphologically and physiologically
istinct and the ECMs these ﬁbroblasts reside also exhibit differ-
nces in terms of their composition and organization (Azzarone
nd Macieira-Coelho, 1982; Schafer et al., 1985; Schönherr et al.,
993; Sorrell et al., 2004). Table 1 highlights the differences
etween papillary dermis and reticular dermis (human) observed
n vivo and through in vitro studies. Papillary dermis is com-
osed of thin, poorly-organized collagen ﬁber bundles while thick,
ell-organized collagen bundles characterize the reticular dermis
Sorrell and Caplan, 2004). The papillary dermis also has a higher
atio of collagen type-III to I, higher levels of decorin, and lower
evels of the chondroitin proteoglycan versican, compared to the
eticular dermis (Schönherr et al., 1993; Sorrell et al., 1999, 2004;
immermann et al., 1994). Similarly, other ECM molecules are alsofferentiates to give rise to different ﬁbroblast populations within the skin. Evidences
ermal ﬁbroblast phenotype.
differentially apportioned between the two dermal compartments.
Such differences in the ECM composition and organization play
a role in controlling the ﬁbroblast behavior and their response
in wound healing and scar formation. In addition, to differences
in the ECM, in vitro studies using papillary and reticular dermal
human ﬁbroblasts demonstrate that these differences between the
dermal layers are reﬂected at the cellular level (Table 1). Papil-
lary dermal ﬁbroblasts display higher growth kinetics and lower
contractile properties in vitro compared to site-matched reticu-
lar ﬁbroblasts (Azzarone and Macieira-Coelho, 1982; Harper and
Grove, 1979; Schafer et al., 1985; Sorrell et al., 2004). Papillary der-
mal  ﬁbroblasts synthesize more decorin, while versican is produced
at higher levels by reticular dermal ﬁbroblasts both in vivo and
in vitro (Schönherr et al., 1993). While Tajima and Pinnell found
no differences between the two ﬁbroblast populations in terms
of synthesis of collagen types-I and III in vitro, they did observe
that media conditioned by papillary dermal ﬁbroblasts had higher
amounts of type I procollagen (Tajima and Pinnell, 1981). Further-
more, Akagi et al. (1999) found higher expression of collagen type
XVI transcripts in ﬁbroblasts derived from the upper layers of the
dermis compared to middle and deeper layers, which correlated
with preferential immunohistochemical labeling for collagen type
XVI in the upper dermis of normal human skin. Collagen type XVI
is a member of the ﬁbril associated collagens and constitutes a
minor component of the skin ECM. However, its presence in the
dermo-epidermal zone of the papillary dermis is associated with
an active role in anchoring microﬁbrils to basement membranes
and hence ensures mechanical anchorage of the basal keratino-
cytes to the basement membrane (Grassel et al., 1999; Kassner
et al., 2003). However, in scleroderma the levels of collagen type XVI
are upregulated and it is expressed in both papillary and reticular
dermis (Akagi et al., 1999). On the other hand, human dermal ﬁbro-
blast senescence in vitro is associated with decrease in expression
of integrin-5 and collagen type XVI resulting in reduced cellular
adhesion (Mancini et al., 2012). Overall, these studies indicate the
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Fig. 2. Adult human skin consists of epidermis and dermis. The epidermis is thrown into folds called rete ridges (A and B). Depending on the region of the body the epidermis
and  its corniﬁed layer various in thickness. For instance, the skin on the back is thin (A), while the skin on the palms is made of thick epidermis and thick stratum corneum
(B).  The dermis is divided into papillary and reticular dermis (C and D) that are separated by a vascular plexus termed the rete subpapillare (D). The papillary dermis contains
higher density of cells and ﬁne collagen bundles compared to reticular dermis that is less cellular and is composed of thick and organized collagen bundles. The arbitrary
dashed line in (C and D) is drawn based on the above-mentioned differences in organization of collagen ﬁbers and location of rete subpapillare. This demarcation between
papillary and reticular dermis could be subjective and might be difﬁcult in skin from older individuals. The papillary and reticular dermis consists of two distinct populations
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ontribution of papillary and reticular dermal ﬁbroblasts towards
ifferences in the ECM composition within the two  compartments
f the dermis in health and diseased states.
Alongside their differences in ECM synthesis, the papillary and
eticular dermal ﬁbroblast populations exhibit distinct patterns of
rowth factor and cytokine secretion that have profound implica-
ions for their paracrine cross-talk with neighboring keratinocytes.
ultured papillary dermal ﬁbroblasts produce a higher ratio of
ranulocyte-macrophage colony stimulating factor (GM-CSF) to
eratinocyte growth factor (KGF) compared to site-matched retic-
lar dermal ﬁbroblasts (Sorrell et al., 2004). Similarly, papillary
ermal ﬁbroblasts express higher levels of interleukin (IL)-6 in vitro
oth constitutively and upon exposure to IL-1 (Sorrell et al., 2004).
ompared to superﬁcial dermal ﬁbroblasts, those cultured from
eeper layers of the dermis express more TGF, connective tis-
ue growth factor, -SMA, heat shock protein 47, type I collagen
nd versican, a phenotype associated with hypertrophic scarring
Varkey et al., 2011; Wang et al., 2008). Global gene expression
roﬁling has revealed that cultured human reticular ﬁbroblasts
verexpress genes involved in cell motility, cytoskeletal organiza-
ion, smooth muscle contraction pathway like -SMA, and neuronal
evelopment (Janson et al., 2012). On the other hand, the cultured
apillary dermal ﬁbroblasts express high levels of genes related
o the complement activation pathway implying its role in skin
mmune response (Janson et al., 2012). Thus, despite their closessociated with dermal papilla and dermal sheath of the hair follicle (E) which are
: kindly provided by Declan Lunny, Institute of Medical Biology, Singapore).
physical proximity, ﬁbroblast populations from the papillary and
reticular dermis are readily distinguished by their phenotypic and
functional features, reﬂecting the distinct physiological niches they
occupy within the skin.
In addition to papillary and reticular ﬁbroblasts, a third clearly
demarcated niche within the skin is occupied by a subpopulation
of dermal ﬁbroblasts that are associated with hair follicles (Fig. 2).
Hair follicles are associated with two ﬁbroblast subpopulations:
FDP ﬁbroblasts and DS ﬁbroblasts. Dermal papillae of the hair folli-
cle consist of a small cluster of densely packed ﬁbroblasts that are
located within the bulb region of the hair follicle (Chuong et al.,
2007). These follicular dermal papilla ﬁbroblasts (FDP ﬁbroblasts)
through interactions with the epithelial cells of the hair follicle,
play a primary role in determination of hair bulb size, length and
diameter of the hair shaft and the duration of anagen phase in the
hair cycle (Schneider et al., 2009). DS ﬁbroblasts are the ﬁbroblasts
present within the loose connective tissue sheath that surrounds
the entire hair follicle (Ohyama et al., 2010). They are separated
from the epithelial outer root sheath of the hair follicle by a spe-
cialized basement membrane called the glassy membrane (Jahoda
and Reynolds, 2001).FDP and DS ﬁbroblasts from human hair follicles differ from
other dermal ﬁbroblasts by their higher expression levels of
non-speciﬁc alkaline phosphatase, -SMA, and protease-activated
receptor-1 in vivo (Anan et al., 2003; Ohyama et al., 2010).
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Table 1
Differences among ﬁbroblasts and the surrounding microenvironment within pap-
illary and reticular dermal layers of the skin.
Papillary dermis Reticular dermis
In-vivo
Collagen type I: type
III (ratio)
Low High
Collagen type IV Positive (basement
membrane)
Negative
Collagen VI Positive (BMZ/DEJ) Weakly positive
Collagen XII Positive Low to Absent
Collagen XIV Low to absent Positive
Collagen XVI Positive (BMZ/DEJ) Negative
-SMA Negative Predominantly
negative (except
positive staining in
dermal sheath and
around blood vessels)
Tenascin-C Positive (BMZ/DEJ) Negative
Tenascin-X Weakly Positive
(BMZ/DEJ)
Positive
Versican Diffusely
weak-positive
(associated with
microﬁbrils)
Positive (along with
elastic ﬁbres)
Decorin Positive Weak positive
Elastic ﬁbers Thin, oriented
perpendicular to DEJ
Coarse, parallel to DEJ
MGP  Weak to Negative Positive
Fibronectin Positive (DEJ and blood
vessels)
Positive (associated
with blood vessels)
Hyaluronan Positive Diffuse
In-vitro
Size and Morphology Spindle-shaped and
thin
Spindle to polygonal;
thick
Proliferation Fast Slow
Vimentin Positive Positive
Versican Negative Positive
Podoplanin Positive Negative
Calponin Negative Positive
Transglutaminase Negative Positive
-SMA Negative Positive/Negative
NTN-1 Positive Negative
KGF Lower Higher
VEGF Higher Lower
TGF-1 Lower Higher
MMPs Higher Lower
TIMPs Higher Lower
-SMA—-smooth muscle actin; BMZ—basement membrane zone; DEJ—dermo-
epidermal junction; KGF—keratinocyte growth factor; MGP—matrix Gla protein;
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instruct the ﬁbroblasts to produce growth factors and cytokines likeMPs—matrix metalloproteinases; NTN-1—netrin-1; TIMPs—tissue inhibitor of
etalloproteinases; VEGF—vascular endothelial growth factor.
owever, the expression of various markers in FDP and DS ﬁbro-
lasts vary depending on species, stage of hair cycle, and whether
hey are analyzed on histological samples or using in vitro cultured
ells. In humans, -SMA is one of the markers that differentiates
S ﬁbroblasts from FDP and other dermal ﬁbroblasts (-SMA is
xpressed only in DS but not in FDP) (Jahoda et al., 1991). How-
ver, upon in vitro culture the FDP ﬁbroblasts become -SMA
ositive (Jahoda et al., 1991). Hence, -SMA could be used as a
arker for DS ﬁbroblasts in vivo, and as a marker for both FDP
nd DS ﬁbroblasts in vitro. Similarly, in human hair follicles (ana-
en), versican is expressed strongly in FDP, while the DS exhibits
eak immunoreactivity. However, its expression in FDP is lost
n miniaturized hair follicles afﬂicted by androgenetic alopecia
Soma et al., 2005), and seems to be upregulated by induction
ith ascorbic acid 2-phosphate (Kim et al., 2006). Though both
DP and DS ﬁbroblasts are specialized ﬁbroblasts of mesenchy-
al  origin, the expression of neuronal markers by FDP ﬁbroblasts,heir transcriptional proﬁle and lineage tracing studies in mice sug-
ests a neural crest origin (Driskell et al., 2009, 2013; Fernandes
t al., 2004; Rendl et al., 2005). Other markers that are reported toell Biology 94 (2015) 483–512
be expressed in mouse/human FDP ﬁbroblasts include perlecan,
syndecan-1, CD133, endothelin-1, nexin-1, stem cell factor and
CD44 (Couchman, 1986; Ohyama et al., 2010; Sorrell and Caplan,
2009). Studies have also shown that human hair follicle associated
ﬁbroblasts express higher amounts of growth factors like stem cell
factor and TGF2 (Chiu et al., 1996; Hibberts et al., 1996); and
lower amounts of matrix metalloproteinases (MMP-3 and MMP-
9) (de Almeida et al., 2005) compared to the interstitial dermal
ﬁbroblasts in vitro. Studies have indicated the presence of hetero-
geneity among FDP ﬁbroblasts from different parts of the body.
For instance, certain subsets of FDP ﬁbroblasts, especially those in
male facial skin, express androgen receptors (Itami et al., 1995),
while those in the skin of the upper legs and buttocks of females
express estrogen receptors (Pugliese, 2007). Further, studies on
FDP ﬁbroblasts from balding and non-balding regions of the scalp
in androgenetic alopecia revealed differences in terms of growth
characteristics, expression of androgen receptors, and senescence
(Bahta et al., 2008; Hibberts et al., 1998; Moon et al., 2013; Randall
et al., 1996). These studies indicate that the ﬁbroblast populations
associated with the hair follicles have important roles in epidermal
morphogenesis, hair morphogenesis, and in regulating abnormal
hair loss.
For many years it has been believed that the dermis contains
well-deﬁned ﬁbroblast subpopulations. It should be noted that
studies show the presence of additional subtypes within the inter-
mediate zones of the dermis (Akagi et al., 1999; Ali-Bahar et al.,
2004), but these populations remain incompletely characterized
and hence, the true extent of dermal ﬁbroblast heterogeneity is not
fully understood. While much remains to be studied, it has long
been known that the ﬁbroblast populations of a given site can be
subdivided by differences in morphology, replicative potential and
biochemical activity, which was  thought to relate to their position
in an ongoing ageing process (Rodemann et al., 1989a). Fibroblasts
were found to exist as either ‘mitotically active’ or ‘replicative
progenitor’ ﬁbroblasts (MF) and ‘irreversible post-mitotic’ ﬁbro-
cytes (PMF), which represent a senescent synthetic phenotype
(Bayreuther et al., 1988a,b; Rodemann et al., 1989a). This led to
a system of classiﬁcation where ﬁbroblasts were subdivided into
MF and PMF  phenotypes (Rodemann et al., 1989a). Besides differ-
ences in their proliferative capacities in vitro, PMFs also produced
5–8 times more total collagen than did MFs  which is thought to
be important for maintaining homeostatic levels of interstitial col-
lagen types I, III and V (Rodemann et al., 1989a). Studies have
shown that the ratio of MFs  to PMFs seems to be important for
the biochemical homeostasis of dermal tissues and in pathologic
tissue remodeling (Bayreuther et al., 1988a; Herskind et al., 1998;
Rodemann et al., 1989b). More recent work has conﬁrmed and
extended this model: clonal studies using cells cultured from the
superﬁcial layer of the dermis detected some rapidly proliferat-
ing cells that are smaller and do not express -SMA, and a second
population of larger, slower proliferating cells that are positive for
-SMA and produced rapid contraction of collagen gels (Sorrell
et al., 2007).
The impact of these observations on ﬁbroblast pheno-
types extends beyond the dermal compartment and into their
interactions with keratinocytes in the epithelium. Fibroblasts
communicate with keratinocytes both through direct cell–cell
interactions and paracrine factors including IL6, IL8, KGF, hep-
atocyte growth factor (HGF) and TGF1 (Boukamp et al., 1990;
Maas-Szabowski et al., 1999; Werner and Smola, 2001; Werner
et al., 1994; Xia et al., 2004). Studies using cocultures of kerati-
nocytes and ﬁbroblasts have demonstrated that the keratinocytesKGF (FGF-7), IL-6, FGF-10 and GM-CSF. IL-1 has been identiﬁed as
one of the primary inducers secreted by keratinocytes (Braun et al.,
2004; Maas-Szabowski and Fusenig, 1996; Maas-Szabowski et al.,
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999; Steiling and Werner, 2003; Werner et al., 1992, 1994). Mono-
ayer and organotypic coculture studies have also revealed that
eratinocyte-derived IL-1 regulates the expression of KGF, GM-CSF,
leiotrophin and stromal-cell derived factor-1 in dermal ﬁbroblasts
hrough transcription factor activated protein-1 (AP-1) (Werner,
998; Werner and Grose, 2003; Werner et al., 1992; Werner and
mola, 2001). These paracrine factors secreted by dermal ﬁbro-
lasts in turn regulate keratinocyte proliferation and differentiation
n cocultures in vitro (Florin et al., 2005). Similarly, a recent study in
ice has demonstrated that targeted deletion of avian myeloblas-
osis viral oncogene (Myb) in K14+ keratinocytes was  associated
ith defects in epithelial proliferation, thickness and morphology
Sampurno et al., 2015). In addition to the effects on epidermis,
eletion of Myb  in keratinocytes was associated with deﬁcient pro-
uction of collagen type-I by ﬁbroblasts, which seems to be due
o a reduced expression of TGF1 by the keratinocytes. All these
bservations underline the concept of double paracrine signaling
etween keratinocytes and ﬁbroblasts, wherein the former initiates
rowth factor production in ﬁbroblasts, which in turn stimulates
eratinocyte proliferation and differentiation. The primary func-
ion of ﬁbroblast-derived paracrine factors is to drive keratinocyte
roliferation and migration, with the exception of TGF1, that
own-regulates proliferation and induces keratinocyte differenti-
tion. Studies using ﬁbroblasts treated with mitomycin-C to mimic
he PMF  phenotype revealed signiﬁcantly higher secretion of KGF
n vitro compared to MF  subtypes, and among the MF  subtypes, MF-
II produced more KGF than MF-II, with MF-I producing the least
Nolte et al., 2008). In parallel, TGF1 is predominantly secreted
y MF-III and PMFs (Nolte et al., 2008). Studies on monolayer and
rganotypic keratinocyte-ﬁbroblast cocultures have also demon-
trated that these differences in KGF secretion are mediated by
P1 complex (Maas-Szabowski et al., 2000, 2001; Szabowski et al.,
000). Hence, via a double paracrine signaling, keratinocytes and
he sub-populations of ﬁbroblasts combine to ﬁne tune the balance
etween keratinocyte proliferation, migration and differentiation,
s well as inﬂuence the ECM synthesis and remodeling in the
ermis.
In addition to the established levels of heterogeneity within the
ermal ﬁbroblast compartment, both internal and external envi-
onmental inﬂuences have roles to play in shaping the ﬁbroblast
opulations in skin. For instance, various characteristics of the
kin differ in anatomically specialized regions: the papillary der-
is  is considerably thicker in certain regions of the body such as
he palmoplantar regions (Cormack, 1987). Moreover, ageing has a
rofound impact on the skin, which becomes progressively thin-
er, losing dermal papillae of the epidermis and experiencing a
eduction of the papillary dermis (Gilchrest, 1996). Interestingly,
apillary dermal ﬁbroblasts appear to be more affected by ageing
han their reticular counterparts: with increasing age, the ﬁbro-
lasts of the papillary dermis become more heterogeneous in terms
f their size and display decreased proliferative rates in culture;
apillary dermal ﬁbroblasts also express increasing amounts of
rowth factors, including vascular endothelial growth factor (VEGF)
ith age, while reticular ﬁbroblasts do not (Mine et al., 2008).
A ﬁnal layer of complexity is added by the understanding
hat, following injury, the local need for replenishment of the
ermal ﬁbroblast compartment can be met  either by prolifera-
ion of existing ﬁbroblasts, from mesenchymal stem cell (MSCs)
r from epithelial cells via a process of epithelial-mesenchymal
ransition (Strutz et al., 1995). Two mesenchymal cell types that
eserve attention are MSCs and perivascular smooth muscle cells
pericytes) (Caplan, 2007; Mills et al., 2013; Paquet-Fiﬁeld et al.,
009). Both these mesenchymal populations express certain mark-
rs expressed by ﬁbroblasts (that includes CD90, CD73, CD105,
DGFR) (Ishii et al., 2005). Studies in mice and humans, sug-
est that activated ﬁbroblasts or myoﬁbroblasts can arise fromell Biology 94 (2015) 483–512 489
resident and/or circulating mesenchymal stem cell (MSC) popula-
tions which originate from the bone marrow, adipose tissue or from
pericytes associated with dermal microvasculature (Badiavas et al.,
2003; Kataoka et al., 2003; Mills et al., 2013; Paquet-Fiﬁeld et al.,
2009; Toma et al., 2001). Though these studies demonstrate the
contribution of circulating MSCs in wound healing, recent lineage
tracing and bone marrow transplantation studies in the mice do not
indicate their contribution to dermis during development of skin
(Barisic-Dujmovic et al., 2010; Driskell et al., 2013; Higashiyama
et al., 2011).
In summary, the skin ﬁbroblast compartment is comprised of
several distinct sub-populations and perhaps also some interme-
diate states between these distinct groups. This heterogeneity
results from differences in embryonic origin, anatomic site and
state of differentiation, as well as micro-environmental inﬂuences
and physiological processes such as ageing. Further, the differences
in morphological, biochemical and functional proﬁles of various
ﬁbroblast populations impact keratinocyte growth and differenti-
ation, and hence, homeostasis of the skin.
3. Insights from hair follicle associated ﬁbroblasts
Hair follicle is a reservoir of stem cells that have the potential
to regenerate hair and the epidermis. Investigations suggest the
existence of stem cell populations within the epithelial outer root
sheath (hair follicle epithelial stem cells) and within the dermal
components of the hair follicle (FDP and DS) (Jahoda et al., 2003;
McElwee et al., 2003; Taylor et al., 2000). The ﬁbroblasts within the
FDP and DS are believed to play an important role in induction,
homeostasis and regeneration of epithelial structures including
hair and epidermis (Gharzi et al., 2003; McElwee et al., 2003;
Messenger et al., 1986). Analysis of cytokinetic dynamics within
FDP and DS suggests bidirectional cell trafﬁcking between the two
compartments during normal hair cycle in mouse and human hair
follicles (Jahoda, 2003; Tobin et al., 2003; Whiting, 2001). These
studies also suggest the existence of progenitors within the DS that
serve as a reservoir for the FDP ﬁbroblasts.
The hair inductive properties of the hair follicle associated ﬁbro-
blasts has been excellently demonstrated by studies using rat
vibrissa or whisker follicles. Implantation of FDP into afollicular
skin or beneath amputated vibrissa hair follicles induces new hair
formation (Jahoda, 1992; Oliver, 1967, 1970). Similarly, cultured
FDP and DS cells also possess the potential to reconstitute a new
FDP in vivo (Horne and Jahoda, 1992; Jahoda et al., 1984; McElwee
et al., 2003; Reynolds et al., 1999). In one of the seminal studies,
implantation of DS from male human scalp into arm of female recip-
ient resulted in growth of a new hair follicle with a FDP containing
Y-chromosome (Reynolds et al., 1999). These observations suggest
the hair inducing ability and probably immune privilege of FDP and
DS ﬁbroblasts.
Based on circumstantial evidence from dermal wound heal-
ing studies in animals and human surgical procedures, Jahoda and
Reynolds (2001) provided two hypotheses. First, the DS ﬁbroblasts
could act as specialized progenitor populations that play a role in
dermal wound healing. Second, involvement of DS ﬁbroblasts in
the wound healing process reduces the likelihood of scarring. To
substantiate the hypotheses, Jahoda and Reynolds (2001) provided
clinical evidences that human scalp skin heals faster compared to
other parts of the body; bald scalp heals slower; ability to obtain
multiple split-thickness grafts from the same donor site on the
scalp skin; and relative lack of occurrence of hypertrophic scars
and keloids on the scalp. Hence, the relative paucity of hair on
most parts of the human skin could probably contribute to inferior
wound healing and scar formation. Furthermore, they suggested
that these DS ﬁbroblasts are an easily accessible source of cells that
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epresent a residual embryonic-type ﬁbroblast population within
he mature skin; and incorporating these cells into full-thickness
kin substitutes could improve wound healing and reduce scar for-
ation (Jahoda and Reynolds, 2001). Recently, two studies have
nvestigated the potential of using DS ﬁbroblasts for reconstruc-
ion of skin substitutes. Cho et al. (2004) compared the ability of
uman DS ﬁbroblasts and dermal ﬁbroblasts to support epider-
al  morphogenesis in vitro using a collagen-based organotypic
kin model. Histologically, the reconstructed skin using DS ﬁbro-
lasts displayed thicker epidermis, stronger expression of ﬁlaggrin,
eratin-1 and integrin-6, a lower number of PCNA-positive cells,
nd weaker transferrin receptor staining compared to those with
ermal ﬁbroblasts. These observations suggest the superior ability
f DS ﬁbroblasts to support epidermal morphogenesis. However,
 recent study comparing human FDP, DS and dermal ﬁbroblasts
ultured within collagen sponges and transplanted onto a full-
hickness defect on the back skin of mice showed no signiﬁcant
ifference in the wound healing abilities between the three ﬁbro-
last subtypes (Shin et al., 2011). However, the synthesis of new
ollagen was superior in the wounds grafted with FDP and dermal
broblasts compared to DS ﬁbroblasts suggesting a superior dermal
rchitecture in the former. Further, the basement membrane for-
ation based on expression of tenascin was superior in skin grafts
ith FDP ﬁbroblasts compared to DS or dermal ﬁbroblasts. Consid-
ring the easily accessibility and embryonic-like nature of hair
ollicle associated ﬁbroblasts, further studies are needed to estab-
ish the probable beneﬁts of these ﬁbroblast subtypes proposed by
ahoda and Reynolds (Jahoda and Reynolds, 2001).
. Insights from in vitro skin models
The clinical need to treat burns and chronic wounds, resulted
n the development of the ﬁrst human skin equivalents in the
arly 1980s (Bell et al., 1981, 1983). Following this pioneering
fforts, there has been several publications on successful recon-
truction of human skin equivalents in vitro. Brieﬂy, ﬁbroblasts
re encapsulated within ECM components like collagen, ﬁbrin or
eeded onto de-cellularized dermis and cultured for a few days to
 week. Then the keratinocytes are seeded on top of the dermal
quivalents, cultured under submerged conditions for few days
nd then the culture is exposed to the air (commonly referred
o as air–lift or air–liquid interface) resulting in epidermal dif-
erentiation, stratiﬁcation and development of a corniﬁed layer
Fig. 3). The various dermal substitutes used for reconstruction of
ull-thickness human skin equivalents include de-cellularized/de-
pidermized dermis (El Ghalbzouri et al., 2002b; Lamb and Ambler,
013; Lee and Cho, 2005), collagen type I (Moulin et al., 1999),
ollagen-gycosaminglycans (Varkey et al., 2011, 2014a,b), ﬁbrin
Boehnke et al., 2007; Mufﬂer et al., 2008; Stark et al., 2004b),
broblast-derived matrix (Janson et al., 2013), and synthetic poly-
ers (Boehnke et al., 2007). Based on these studies, various
ompanies and start-ups have developed in vitro skin tissue equiva-
ent models for pharmaceutical, cosmetic and chemical compound
creening and testing. These commercially available skin tissue
quivalents for in vitro testing are listed in Table 2.
In recent years, these full-thickness organotypic cultures have
een increasingly employed in skin research. These models offer
igniﬁcant advantages over the traditional monolayer cocultures
ut also differ in important ways from natural skin tissue:
rganotypic cultures predominantly utilize mitotically-active early
assage ﬁbroblasts derived from human foreskins, abdomen, fore-
rm or breast tissues which proliferate within the dermal matrix
esulting in 3–4 fold increase over a 3 week culture period (Boehnke
t al., 2007; Maas-Szabowski et al., 2000). As the majority of ﬁbro-
lasts in normal skin are generally in a resting non-proliferativeell Biology 94 (2015) 483–512
state, this represents a potentially signiﬁcant difference and
also introduces the additional variable of changing numbers of
ﬁbroblasts within the culture period, which impedes investiga-
tion of epithelial-mesenchymal interactions. Certain studies have
explored the potential for combining the advantages of the organ-
otypic approach with the added control of employing irradiated
ﬁbroblasts to populate the dermal matrix (Maas-Szabowski et al.,
2000). The authors show that the morphology of the reconstructed
epidermis is similar in organotypic co-cultures of keratinocytes
with irradiated or non-irradiated dermal ﬁbroblasts, and that
problematic contraction of the collagen-based dermal matrix is
less when irradiated ﬁbroblasts are used. Hence, non-proliferative
inactivated PMFs might be advantageous for use in organotypic cul-
tures for several reasons: they more closely replicate the resting
state of ﬁbroblasts in native dermis, they reduce shrinkage of colla-
gen gels, and their population size remains stable within the dermal
matrix over the culture period (Maas-Szabowski et al., 2000). How-
ever, using PMFs for long-term cultures of over 3–4 weeks may  not
be suitable due to decrease in their numbers over the long culture
period. As described above, native skin is composed of a ratio of
MFs  and PMFs, which is required for biochemical homeostasis of
the dermis. Hence, it would be interesting to investigate the inﬂu-
ence of speciﬁc ratios of MFs  and PMFs in organotypic cultures on
dermal and epidermal architecture.
Regardless of the source and mitotic state of ﬁbroblasts used,
their importance in driving optimal epidermal morphogenesis in
engineered skin substitutes is clear. Collagen-based skin equiv-
alents lacking ﬁbroblasts exhibit an atrophic epithelium which
is poorly organized and lack corniﬁcation (Boehnke et al., 2007;
Contard et al., 1993; El Ghalbzouri et al., 2002b, 2004). Simi-
larly, in ﬁbrin-based skin equivalents, the absence of ﬁbroblasts
is associated with an atrophic epithelium possessing just 3–4 lay-
ers of keratinocytes, lack of a deﬁned stratum granulosum, and
display the parakeratinization (presence of nuclear remnants in
the corniﬁed layer) instead of orthokeratinization. Reinstating a
ﬁbroblast compartment induces the development of 5–8 epider-
mal  layers with well-deﬁned stratum granulosum and a uniform
orthokeratinized layer (Fig. 4). Further, studies also reveal the
importance of ﬁbroblast-keratinocyte cross-talk for the generation
of a well-organized basement membrane, which was conven-
tionally thought to be a purely keratinocyte-driven process (for
excellent reviews on basement membrane organization and epi-
dermal morphogenesis see, Breitkreutz et al., 2013; McMillan et al.,
2003; Miner, 2008; Miner and Yurchenco, 2004).
Studies on organotypic cultures on type I collagen and de-
epidermized dermis have demonstrated the role of keratinocyte-
ﬁbroblast interactions that inﬂuence the formation of basement
membrane and which in turn can inﬂuence the keratinocyte phe-
notype (El Ghalbzouri et al., 2004). While keratinocytes produce the
majority of the components of the basement membrane, expression
of bullous pemphigoid (BP) antigens BP230 and BP180, laminins
and type IV collagen are weak and delayed in the absence of ﬁbro-
blasts (El Ghalbzouri et al., 2005; Lee and Cho, 2005; Okamoto and
Kitano, 1993; Schafer et al., 1991). Moreover, we  now know that
certain components of the basement membrane like laminin-10,
nidogens/entactin are produced primarily by dermal ﬁbroblasts
(Contard et al., 1993; Fleischmajer et al., 1995; Mokkapati et al.,
2008; Nischt et al., 2007), while components like laminin-5 and
collagen VII are primarily produced by keratinocytes (Marinkovich
et al., 1993), and other components are produced by both cell
types through mutual interactions. However, the primary role of
ﬁbroblasts appears to be their instructive effects on keratinocytes,
promoting both the production of basement membrane compo-
nents and appropriate organization of the basement membrane
zone (Lee and Cho, 2005). Other studies have similarly empha-
sized the importance of ﬁbroblast-keratinocyte communication in
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Fig. 3. Schematic representation of culture of organotypic skin model. Dermal matrices with or without ﬁbroblasts are cultured under submerged conditions within a culture
insert  (A). After a few days, keratinocytes are seeded on top of the dermal matrices (B). After a few days of submerged culture of keratinocytes, the culture is exposed to air
allowing the media to perfuse only through the dermal side (C). This process of culturing the keratinocytes at an air–liquid interface results in their differentiation, formation
of  a stratiﬁed and corniﬁed epidermis (D).
Table 2
Commercially available organotypic skin equivalents for in vitro testing and related applications.
Brand name Manufacturer/service
provider
Cells Scaffold
Epidermis
models
epiCS (EST-1000) CellSystems (Germany) Human keratinocytes Polycarbonate membrane
Epiderm MatTek Corp. (USA) Human keratinocytes (neonatal/adult) Collagen-coated
polycarbonate membrane
Leiden epidermal skin
model (LEM)
Biomimiq (Netherlands) Human keratinocytes (neonatal/adult) Inert acellular ﬁlter
SkinEthic RHE EpiSkin (France) Human keratinocytes (neonatal/adult) Polycarbonate membrane
epiCS-M CellSystems (Germany) Human keratinocytes with human
melanocytes from donors of three different
phototypes: Caucausian, Afro-American
and Asian-Caucasian
Polycarbonate membrane
MelanoDerm MatTek Corp. (USA) Human keratinocytes and human
melanocytes from donors of three different
phototypes: African, Caucausian and Asian
Inert cell culture insert
membrane
SkinEthic RHPE EpiSkin (France) Human keratinocytes and human
melanocytes
Inert cell culture insert
membrane
Full  thickness
skin models
3D HSE MD Biosciences
(Switzerland) and
Fraunhofer IGB (Germany)
Human keratinocytes and ﬁbroblasts Proprietary: Biomatrix
consisting of tissue-typical
matrix proteins
AST-2000 (discontinued) CellSystems (Germany) Human keratinocytes and ﬁbroblasts Collagen
Epiderm-FT MatTek Corp. (USA) Human keratinocytes and human
ﬁbroblasts (neonatal/adult)
Collagen
EpiSkin EpiSkin (France) Human keratinocytes (neonatal/adult) Collagen
Fibroblast-derived matrix
model (FDM)
Biomimiq (Netherlands) Human keratinocytes and ﬁbroblasts
(neonatal/adult)
Human ﬁbroblast-seeded
dermal matrix
Full  thickness model (FTM) Biomimiq (Netherlands) Human keratinocytes and ﬁbroblasts
(neonatal/adult)
Human ﬁbroblast-seeded
collagen matrix
Phenion FT Henkel AG & Co. (Germany) Human keratinocytes and ﬁbroblasts
(neonatal foreskin)
Bovine, cross-linked
lyophilized collagen
StrataTest Stratatech (USA) Immortalized human keratinocyte
progenitor cell line (NIKS) and dermal
ﬁbroblasts
Collagen I
Vascularized 3D HSE MD Biosciences
(Switzerland) and
Fraunhofer IGB (Germany)
Human keratinocytes, ﬁbroblasts and
microvascular endothelial cells
3D HSE vascularized with
BioVasc technology
(decellularized jejunum
seeded with microvascular
endothelial cells)
Iseased skin
models
Melanoma tissue model
(MLNM-FT-A375)
MatTek Corp. (USA) Human malignant melanoma (A375) cells
combined with EpiDerm-FT tissues
Collagen
Psoriasis tissue model
(SOR-300-FT)
MatTek Corp. (USA) Normal human keratinocytes with
psoriatic ﬁbroblasts within EpiDerm-FT
Collagen
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Sasement membrane formation, rather than a predominant role of
ust one cell type (Fleischmajer et al., 1998; Smola et al., 1998). For
nstance, ﬁbroblasts express TGF2 upon induction by keratino-
ytes, and this TGF2 in turn regulates the production of collagen
ype VII and laminins by keratinocytes locally in a paracrine man-
er (König and Bruckner-Tuderman, 1991, 1992, 1994; Smola et al.,
994, 1998). Further, in organotypic cultures, collagen type IV and
II, laminin-5, laminin-10/11, nidogens, and uncein are expressed
nly in the presence of ﬁbroblasts or ﬁbroblast-expressed solu-
le factors like EGF, KGF and GM-CSF (El Ghalbzouri et al., 2005;
mola et al., 1998). Studies on organotypic mono-/cocultures oftissues
human keratinocytes and ﬁbroblasts have demonstrated that colla-
gen VII (an integral part of anchoring ﬁbrils) is primarily produced
by keratinocytes; and collagen VII expression is highly upregulated
in the presence of ﬁbroblasts and TGF2 (König and Bruckner-
Tuderman, 1991, 1992, 1994; Smola et al., 1998; Stark et al.,
2004b). Similarly, studies on mice and organotypic cultures have
demonstrated the role of perlecan, laminins, and nidogens-1 and
-2 in the assembly of basement membrane components (Bader
et al., 2005; Mokkapati et al., 2008, 2011; Nischt et al., 2007; Sher
et al., 2006). Sher et al. (2006) investigated the role of perlecan
in the formation of human epidermis using organotypic cultures.
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Fig. 4. Organotypic culture of N/TERT-1 keratinocytes over ﬁbrin-based dermal matrices without ﬁbroblasts under serum-free, deﬁned conditions result in an epithelium
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atrix results in a well-organized epidermis with well-deﬁned stratum granulosum
pinosum. Scale bar: 50 m.
rganotypic cultures with ﬁbroblasts lacking perlecan displayed no
ffect on basement membrane organization and epidermal mor-
hology. However, organotypic cultures with perlecan-deﬁcient
eratinocytes displayed atrophic and poorly organized epidermis
ue to enhanced apoptosis. Similarly, nidogen plays a part in assem-
ly of basement membrane components, through its role as a linker
oining laminin and collagen IV. Lack of both nidogen -1 and -2
n organotypic cultures of human keratinocytes and murine ﬁbro-
lasts (with varying nidogen deﬁciency) prevented the deposition
nd ultrastructural assembly of basement membrane, while the
xpression or supplementation of either isoform restored the base-
ent membrane structure suggesting the role of ﬁbroblasts in
idogen expression and in turn basement membrane organization
Mokkapati et al., 2008, 2011; Nischt et al., 2007). Additionally,
nteraction between laminin and nidogen may  have an inﬂuence
n the epidermal stem cell phenotype (Paquet-Fiﬁeld et al., 2009;
ouliot et al., 2002; Pujuguet et al., 2000). Hence, ﬁbroblasts play
 direct and a paracrine role in synthesis, assembly and organiza-
ion of the basement membrane; and organotypic cultures provide
 valuable platform to study basement membrane organization
n vitro.
Given the multiple and varied roles of ﬁbroblasts in the skin,
t is perhaps not surprising that the precise conditions of their
nclusion in in vitro co-culture models has a profound effect on the
esulting epidermis. Initial investigations in organotypic cultures
ndicate that increasing concentrations of ﬁbroblasts conferred
mproved epidermal architecture (El Ghalbzouri et al., 2002a).
ow ﬁbroblast concentrations (2 × 104 ﬁbroblasts/ml) are associ-
ted with expression of involucrin in the suprabasal layer, and
he presence of the keratinocyte activation markers K6, K16 and
17 in a pattern normally seen in regenerating epidermis; while at
igher concentrations (8 × 104 ﬁbroblasts/ml) involucrin expres-
ion is restricted to the stratum granulosum and K6, K16 and K17
re not expressed, similar to native human skin (El Ghalbzouri
t al., 2002a; Stark et al., 1999). Attempts to optimize such vari-
bles as timing of keratinocyte addition to the co-culture, ﬁbroblast
reconditioning and ﬁbroblast densities suggest that overnight
reconditioning of ﬁbroblast-populated collagen matrices (before
eratinocyte seeding) are associated with lower collagen matrix
ontraction with increasing ﬁbroblast densities; while 1-week pre-
onditioning induces marked matrix contraction irrespective of
broblast concentration (El Ghalbzouri et al., 2002a). As explained
lready, organotypic culture of full-thickness skin equivalents
rincipally involves the following steps: seeding and culture of
broblasts onto/within dermal matrices followed by keratinocyte
eeding and culture at air–liquid interface. The initial phase ofC-Para) (A). On other hand culture over ﬁbroblast populated ﬁbrin-based dermal
and a uniform layer of orthokeratin (SC-Ortho) (B). SB—stratum basale; SS—stratum
culturing ﬁbroblasts encapsulated within/seeded on dermal matri-
ces prior to the addition of keratinocytes is referred to as ﬁbroblast
pre-conditioning. Similarly, we  observed contraction of collagen-
based dermal matrix with and without the presence of ﬁbroblasts,
while contraction of the ﬁbrin-based dermal matrix was  mini-
mal  irrespective of the presence or absence of ﬁbroblasts (Fig. 5).
However, studies using ﬁbrin-based dermal matrices suggest that
pre-conditioning for 2 days results in superior epidermal morpho-
genesis and basement membrane development compared to 7 and
14 days of ﬁbroblast pre-conditioning (Boehnke et al., 2007). Exper-
iments with scaffold-reinforced ﬁbrin-based dermal matrices and
extended culture periods of up to 12 weeks have previously been
reported (Boehnke et al., 2007; Mufﬂer et al., 2008), highlighting the
inherent properties of different dermal matrices and the potential
enhancements that may  be made to culture models under the right
conditions.
Interestingly, the role of ﬁbroblast heterogeneity in epidermal
morphogenesis of organotypic skin equivalents is increasingly rec-
ognized. Papillary dermal ﬁbroblasts appear to induce basement
membrane formation more rapidly in 3D cocultures than the site-
matched reticular dermal population (Sorrell et al., 2004). Hence,
it is possible that the ﬁbroblast subpopulations closest to the epi-
dermis either produce more basement membrane components or
higher amounts of the paracrine factors that drive keratinocyte to
establish and organize the basement membrane. In addition, to
the role of ﬁbroblast heterogeneity in basement membrane orga-
nization, studies highlight their role in epidermal organization. It
is well established that balanced production of various paracrine
factors like KGF-1, GM-CSF, and IL-1 is required for appropriate
keratinocyte differentiation and epidermal morphogenesis (Maas-
Szabowski et al., 2001; Sorrell et al., 2004). Cultured papillary
dermal ﬁbroblasts secrete higher levels of GM-CSF to KGF-1 com-
pared to site-matched reticular dermal subpopulations (Sorrell
et al., 2004). Given that ﬁbroblast subpopulations can express dif-
ferent levels of these bioactive factors, it is imperative that the most
appropriate ﬁbroblast subpopulation is identiﬁed for use in speciﬁc
skin tissue engineering applications.
Differences in the ECM and ﬁbroblasts of papillary and retic-
ular dermis may  play a role in engineering skin equivalents.
The work by Lee and Cho (2005) has shown the importance
of these layers of dermis on epithelization in culture (Lee and
Cho, 2005). Organotypic culture of keratinocytes on reticular
layer of decellularized dermis gives rise to multi-layered epider-
mis  without corniﬁcation, the basal keratinocytes are ﬂat and
arranged parallel to dermo-epidermal junction, and components
of basement membrane are poorly expressed and organized. On
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Fig. 5. Organotypic cultures of N/TERT-1 keratinocytes over ﬁbroblast populated collagen-based dermal matrix under serum-free deﬁned conditions results in variable
contraction of the culture (A) as could be visualized by the difference in area enclosed in red (original area occupied by the gel before contraction) and in yellow (area
occupied by the gel after contraction). On the other hand, organotypic cultures on ﬁbroblast populated ﬁbrin-based dermal matrix show almost no contraction (B). The
lower  panel shows the histological picture of the organotypic skin formed after 3 weeks of culture on collagen (C) and ﬁbrin (D) based dermal matrices. SB—stratum basale;
S : 50 
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eferred to the web  version of this article.)
he other hand, culture of keratinocytes on the papillary layer
f decellularized dermis show multi-layered epithelium with
hick corniﬁed layer similar to that observed in vivo, the basal
eratinocytes are polarized with their long axes oriented per-
endicular to the dermo-epidermal junction; and characterized
y expression of well-organized deposition of basement mem-
rane components (collagen-IV, collagen-VII, integrin-4, laminin,
nd tonoﬁbril-hemidesmosome complexes). Similarly, Varkey et al.
2011, 2014a,b) in a series of publications have demonstrated the
uperiority of papillary (superﬁcial) ﬁbroblasts compared to retic-
lar (deep) dermal ﬁbroblasts for construction of tissue engineered
kin equivalents. Collagen-glycosaminoglycan matrices cultured
ith reticular dermal ﬁbroblasts demonstrate higher contraction
nd stiffness of the matrix compared to those with papillary ﬁbro-
lasts; in addition the matrices with reticular ﬁbroblasts show
igniﬁcantly higher -SMA staining (probable differentiation to
yoﬁbroblast-like phenotype), higher production of pro-ﬁbrotic
actors TGF1 and osteopontin (Varkey et al., 2011, 2014a). Fur-
her, the culture of keratinocytes with superﬁcial dermal ﬁbroblasts
esult in superior epidermal morphogenesis in terms of higher
xpression levels of proteins related to epidermis and basement
embrane, are less ﬁbrotic, and has superior epidermal barrier
unction compared to those cultured with deep dermal ﬁbroblasts
Varkey et al., 2014a,b). Similarly, a recent study demonstrated
he differential regulation of epidermal proliferation and terminal
ifferentiation by papillary and reticular ﬁbroblasts in ﬁbroblast-
erived matrix organotypic cultures (Janson et al., 2013). The skin
quivalents with papillary ﬁbroblasts demonstrate superior epi-
ermal morphogenesis as revealed by deﬁned basal layer with
olarized basal keratinocytes, and deﬁned stratum granulosum
ith stronger expression of ﬁlaggrin and loricrin, and a thick
orneal layer. Further, organotypic cultures with papillary ﬁbro-
lasts demonstrated increased synthesis of MMP-1 and VEGF,
hile those with reticular ﬁbroblasts showed higher levels of
MP-3 and KGF synthesis (Pageon et al., 2012). Together these
tudies suggest that primary ﬁbroblast isolation from the der-
is  should take into account the differences in the papillarynd reticular dermal ﬁbroblasts, and that appropriate popula-
ions of ﬁbroblasts should be isolated and used for engineering
kin substitutes rather than a heterogeneous mixture of dermal
broblasts.m.  (For interpretation of the references to color in this ﬁgure legend, the reader is
As the role of inherent differences in the papillary and reticular
dermal ﬁbroblast phenotypes is increasingly recognized, another
factor that inﬂuences the difference between these two pheno-
types is also beginning to be understood. Interestingly, studies
have observed differences in the papillary and reticular dermal
ﬁbroblasts with physiological ageing and its impact on epidermal
morphogenesis. Site-matched studies on skin biopsies obtained
from young and old donors show thinner epidermis with shorter
rete ridges, ﬂatter dermo-epidermal junction and more disorga-
nized collagen ﬁbers in the dermis in the older individuals (Mine
et al., 2008). Further, in vitro studies show that site-matched pap-
illary dermal ﬁbroblasts show that these dermal ﬁbroblasts from
older individuals are more heterogeneous in their size proﬁle and
have a slower proliferation rate. Accordingly, aging papillary ﬁbro-
blasts (in vitro) exhibited upregulation in the secretion proﬁles of
KGF, VEGF, MMPs  (-1, -2 and -3) and tissue inhibitor of metallopro-
teinases (TIMP-1 and TIMP-2), while there is no difference among
the reticular ﬁbroblasts with age (Mine et al., 2008). Organotypic
cultures of these dermal ﬁbroblasts also exhibit differences in their
ability to contract. Papillary dermal ﬁbroblasts from older donors
contract collagen gels more than those from younger donors, while
again there is no difference among the reticular dermal ﬁbro-
blasts with age. Finally, organotypic cocultures of keratinocytes
and ﬁbroblasts, show thicker epidermis with well-deﬁned stratum
corneum and orthokeratinization in cultures with papillary der-
mal  ﬁbroblasts from younger donors; while those with papillary
dermal ﬁbroblasts from older donors had thinner epidermis and
stratum corneum (similar to those cultures with young or old
reticular dermal ﬁbroblasts). These differences were also evident
upon transplantation into nude mice (Mine et al., 2008). Hence,
the aging of the papillary dermal ﬁbroblasts might account for
the epidermal atrophy and loss of rete ridges with age. Similarly,
another study has highlighted the effect of aging induced by long-
term culture of the ﬁbroblasts on the epidermal morphogenesis.
Equivalents with early-passage papillary ﬁbroblasts demonstrated
well organized epidermis, while those with late-passage papillary
ﬁbroblasts resembled those with reticular ﬁbroblasts (Janson et al.,
2013). Interestingly, the skin equivalents with early-passage ﬁbro-
blasts lacked the expression of keratin-16 (a marker associated
with activated keratinocyte phenotype) indicating the superiority
of these skin equivalents. Additionally, organotypic cultures with
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ate passage reticular ﬁbroblasts were accompanied by atrophic
pithelium. These results suggest the probability of differentiation
f papillary ﬁbroblasts to reticular ﬁbroblast-like phenotype upon
ong-term culture accompanied by poorer ability to support epider-
al  morphogenesis and resemblance to a more ‘aged’ phenotype.
aken together, these studies indicate that future attempts at skin
issue engineering should consider the phenotype of dermal ﬁbro-
lasts, age of the donor, duration of in vitro culture, the expression
f reticular ﬁbroblast/myoﬁbroblast-related markers like -SMA,
nd/or expression of paracrine, pro-ﬁbrotic, and anti-ﬁbrotic fac-
ors.
In addition to the ﬁbroblasts from dermis and FDP, ﬁbroblasts
erived from other sources such as the pericytes surrounding the
ermal microvasculature deserve consideration. These perivas-
ular cells possess mesenchymal stem cell-like properties with
ropensity to differentiate to osteogenic, chondrogenic and adi-
ogenic lineages in addition to their ability to be activated to
broblast-like cells. A recent study investigated the effect of per-
cytes incorporated within organotypic cocultures with human
eratinocytes (Paquet-Fiﬁeld et al., 2009). Coculture with peri-
ytes resulted in enhanced deposition of laminin-511/521 in the
ermal-epidermal junction. More importantly, in contrast to der-
al  ﬁbroblasts, pericytes were demonstrated to rekindle the tissue
egenerative capacity of human keratinocytes committed to differ-
ntiation (Integrin-6dim epidermal cells) probably through their
ecreted factors. This ﬁnding indicates superior support offered
y the pericytes in organotypic cocultures and probably in wound
ealing. However, studies in human wounds suggest that pericytes
nlike other MSCs are more likely to promote ﬁbrosis than to accel-
rate wound healing (Sundberg et al., 1993). Further studies on
ericyte-derived ﬁbroblasts are necessary to understand their role
n skin homeostasis.
Recently, attention has been focused on understanding the
euro-endocrine properties of human skin that includes the
xpression and function of speciﬁc receptors and synthesis of
ormones, neurotransmitters and steroids. In this section of
he review, the role of various neuro-endocrine properties and
on-neuronal receptor systems are brieﬂy discussed. The hor-
onal receptor system includes the expression of parathyroid
ormone/parathyroid hormone-related peptide, thyroid stimulat-
ng hormone, corticotropin-releasing hormone, melanocortin and
elatonin receptors. Though investigations suggest the existence
f these receptors in epidermal and/or dermal compartments, they
ave been primarily focused on skin keratinocytes and informa-
ion on their role and expression among the heterogeneous dermal
broblasts is limited. Studies suggest the expression of neurohor-
one receptors and neurotransmitter systems in non-neuronal
kin cells which are involved in skin homeostasis and inﬂamma-
ion (for excellent reviews refer to Grando et al., 2006; Kurzen
t al., 2007; Raap and Kapp, 2010; Roosterman et al., 2006; Truzzi
t al., 2011). These include acetylcholine (nicotinic and muscariner-
ic), adrenergic, histamine, opioid, cannabinoid, kinin, prostanoid,
asoactive intestinal peptide, somatostatin and neuropeptide-Y
eceptors. Nicotinergic and mucarinergic acetyl choline receptors
nAChR and mAChR) are reported to control epidermal homeostasis
nd terminal differentiation in vitro and in skin of mice (Arredondo
t al., 2002, 2003b; Nguyen et al., 2004). Organotypic cocultures of
uman keratinocytes and ﬁbroblasts treated with nicotine display
yperplastic epidermis; and blockade of nAChR lead to delay in
pidermal proliferation and differentiation evidenced by reduced
pidermal thickness and terminal differentiation markers (Hana
t al., 2007; Kurzen et al., 2006). Though these investigations have
rimarily focussed on epidermis, exposure of dermal ﬁbroblasts
o nicotine results in increase in cell cycle and apoptosis related
egulators; and upregulation of MMP-1 and collagen type-I sug-
esting an alteration in ECM turnover which in turn could affect theell Biology 94 (2015) 483–512
epidermal morphogenesis (Arredondo et al., 2003a). We and others
have established the role of opioid receptors in skin homeosta-
sis and differentiation (discussed in detail under the section on
keloids) (for reviews see, Bigliardi and Bigliardi-Qi, 2014; Bigliardi
et al., 2009). Similarly, studies have observed that adrenergic recep-
tors play a role in the pathophysiology of various skin diseases such
as psoriasis, atopic dermatitis, vitiligo and scleroderma through
their effect on keratinocyte migration and wound reepithelization
(Grando et al., 2006; Sivamani et al., 2007).
Another group of receptors expressed in the skin are the nuclear
receptors that include glucocorticoid, androgen, progesterone,
thyroid hormone, estrogen, vitamin D, peroxisome proliferative-
related receptors (PPAR), retinoid acid (RAR) and retinoid X (RXR)
receptors. The importance of these receptor systems in epidermal
morphogenesis have been recognized by earlier studies includ-
ing hydrocortisone, triiodothyronine, vitamin D, retinoic acid, and
progesterone as media supplements for in vitro organotypic skin
cultures (Asselineau et al., 1989; Crowe et al., 1991; Gangatirkar
et al., 2007; Isseroff et al., 1989; Kaplan et al., 1988; Sorensen
et al., 1997). Glucocorticoids are well known to induce epider-
mal  atrophy and hair growth, presumably due to their effects
on dermal ﬁbroblasts (Gysler et al., 1997; Stratakis et al., 1998).
Studies on human skin and monolayer keratinocyte cultures show
that glucocorticoids regulate keratinocyte differentiation by sup-
pressing the expression of basal cell speciﬁc keratins (K5 and
K14), and keratins associated with activated phenotype (K6, K16
and K17) (Radoja et al., 2000). Androgen and estrogen receptors
are reported to be strongly expressed in both keratinocytes (epi-
dermal and follicular keratinocytes) and ﬁbroblasts (dermal and
follicular). Though investigations suggest that androgens stim-
ulate the proliferation of FDP ﬁbroblasts, excessive amounts of
androgens are shown to induce apoptosis of cultured human FDP
ﬁbroblasts through the bcl-2 pathway and hence, play a role in
androgenetic alopecia (Randall et al., 1992; Winiarska et al., 2006).
Estrogens on the other hand, are well known to improve the qual-
ity of human skin by their effects on collagen content (increased
total collagen and ratio of type III:I collagen), stratum corneum
(increased water-holding capacity), hair growth, enhanced vascu-
larization and increased skin thickness (Brincat, 2000; Thornton,
2002; Verdier-Sevrain et al., 2006). Considering the effects of
androgens and estrogens on epidermal homeostasis, it would be
interesting to investigate their effects in organotypic cultures. Sim-
ilarly, in vitro studies on monolayer and organotypic skin cultures
have shown the effects of retinoic acid on keratinocyte differ-
entiation and proliferation in normal and diseased human skin
(Asselineau et al., 1989; Asselineau and Darmon, 1995; Choi and
Fuchs, 1990; Fuchs and Green, 1981; Jean et al., 2011; Kautsky et al.,
1995). Further, studies have demonstrated that retinoic acid modu-
lates the epithelial differentiation through its effects on expression
of keratins K19, K1/K10 and K4/K13 (Crowe et al., 1991; Kopan et al.,
1987; Schon and Rheinwald, 1996). Studies on organotypic cultures
and humans, have demonstrated that retinoids promote prolifer-
ation in normal human skin, while they have an anti-proliferative
effect with normalization of the differentiation process in psoriatic
skin (Asselineau and Darmon, 1995; Giltaire et al., 2009; Gottlieb
et al., 1996; Heise et al., 2006; Jean et al., 2011). Similarly, in vitro
studies have shown the anti-proliferative and pro-differentiating
effects of vitamin D3 and triiodothyronine (Isseroff et al., 1989;
Sorensen et al., 1997).
In summary, over the recent years and with the advent of organ-
otypic models our knowledge of skin biology and of the roles
of ﬁbroblasts/ﬁbroblast-keratinocyte cross-talk has grown signiﬁ-
cantly. However, even the best in vitro models of native skin cannot
be expected to recapitulate all aspects of the complexity of the
in vivo situation, for instance, the impacts of barrier property, inner-
vation, a continuous blood supply, presence of skin appendages,
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nd interactions with immune cells. This is particularly relevant
or the development of skin substitutes for clinical use, as they will
nvariably be required in cases where the normal architecture of
he skin has been destroyed by wounding and heavy inﬂammation.
nderstanding the wound healing process is a pre-requisite to the
esign of biological skin replacements that are able to reinstate
ormal architecture and function to the affected region. For this,
e turn our attention to studies of healing, and the roles played by
arious ﬁbroblast subpopulations.
. Insights from wound healing studies
Skin healing requires complex interactions between keratino-
ytes, ﬁbroblasts, ECM, and stem cell populations within the basal
pidermis, appendages and underlying mesenchyme. In adults, the
ealing of large and/or full-thickness wounds is invariably asso-
iated with the formation of scar tissue, and numerous studies
ndicate a role for ﬁbroblasts in this process, which will be discussed
elow. Also of particular interest are the specialized situations
here scarless wound healing occurs, such as in ﬁrst and second
rimester fetal skin (Lorenz et al., 1992, 1995), and the oral mucosa,
here ﬁbroblasts are pivotal in directing complete regeneration
f the affected tissue. Thus understanding the mechanisms under-
ying the two ends of the wound healing spectrum will provide
aluable insights into optimal engineering of replacement skin tis-
ues favoring maximal skin regeneration with minimal scarring.
.1. Roles of fetal ﬁbroblasts in scarless healing
The early-gestation fetus has a unique ability to completely heal
kin wounds without forming a scar (Lorenz et al., 1993; Rowlatt,
979). Hence, there has been much interest in understanding the
actors and mechanisms underlying the scarless healing pattern
bserved with the aim of incorporating fetal factors in reﬁned
kin tissue engineering protocols. Initially it was proposed that
spects of the uterine environment and/or components of the amni-
tic ﬂuid, which is rich in growth factors and ECM molecules,
ere responsible for the scarless phenotype (Longaker et al., 1989,
990a, 1991; Mast et al., 1993; Whitby and Ferguson, 1991b).
owever, neither the application of amniotic ﬂuid nor the per-
usion of fetal blood prevented scarring in wounded adult skin
rafts (Longaker et al., 1994). Additionally, scarless wound heal-
ng is restricted to the ﬁrst 24 weeks of human gestation, while
fter this time wounds heal with ﬁbrosis and scarring despite a rel-
tively similar intrauterine environment (Longaker et al., 1990b).
he high regenerative capability of early to mid-gestational fetal
kin has been demonstrated across many mammalian species
ncluding mice, rats, sheep, monkeys and humans (Adzick and
ongaker, 1991, 1992; Ihara et al., 1990; Lorenz et al., 1992, 1993),
ndicative of an evolutionarily conserved mechanism. Further-
ore, as gestation proceeds the ability to heal comparable wounds
ithout scarring is progressively lost; in fetuses of non-human pri-
ates a sequential loss of ability to regenerate hair follicles and
ther appendages occurs in mid-gestation, followed by disorga-
ized deposition of collagen following wounding in late-gestation
Lorenz et al., 1993). The concept that scarless healing is an inher-
nt property of early-gestation fetal skin is further supported by the
nding that subcutaneous transplantation of full-thickness human
etal skin grafts into adult athymic mice, followed by wounding
esults in scarless repair; while transplantation onto cutaneous fas-
ial bed is associated with scarring (Lorenz et al., 1992). Detailed
haracterization of the implanted fetal skin indicate that it is the
etal ﬁbroblast within the graft that is responsible for determin-
ng the scarless versus scarring phenotype (Lorenz et al., 1995), and
hus the focus of research shifted to investigating the cellular andell Biology 94 (2015) 483–512 495
molecular mechanisms of fetal wound healing and how they differ
from those in the adult.
In fact, fetal and adult ﬁbroblasts are distinct in several impor-
tant respects; ﬁbroblasts from fetuses differ in their ability to
synthesize and degrade ECM, and have higher proliferative and
migratory activity that decreases with increasing age (Schor et al.,
1985; Shiraha et al., 2000). The increased migration of murine
fetal ﬁbroblasts may relate to the earlier expression of ﬁbronectin
and tenascin, which promote rapid re-epithelialization following
wounding (Carter et al., 2009; Whitby et al., 1991). Additionally,
while wound healing in the adult is associated with initial pro-
liferation of ﬁbroblasts followed by synthesis of ECM, in the fetal
wound, wound ﬁbroblasts proliferate and deposit ECM simulta-
neously (Larson et al., 2010). The differences in healing dynamics
and the reduced migratory ability of adult dermal ﬁbroblasts and
delay in deposition of collagen in adult wounds is believed to be
an important factor in delayed wound healing and scar forma-
tion. As well as synthesizing ECM relatively earlier in the wound
healing process, the composition of the matrix deposited by fetal
ﬁbroblasts is different; fetal ﬁbroblasts (mice and rats) synthesize
higher amounts of total collagen and a higher proportion of collagen
type-III relative to type-I than do adult dermal ﬁbroblasts (Carter
et al., 2009; Hallock et al., 1988, 1993; Merkel et al., 1988). Second,
30–60% of the collagen in the dermis of fetal skin is collagen type-III,
while in the adult dermis collagen type-III accounts for only 10–20%
of the total collagen (Bullard et al., 2003). This difference in ratio
between collagen types is potentially signiﬁcant, as collagen type-
III ﬁbers are much shorter and ﬁner than those of collagen type-I.
Thus, the particular collagen composition of fetal skin is associated
with deposition of collagen ﬁbers in a ﬁne reticular pattern with
less cross-linking, as opposed to the thick, disorganized collagen
ﬁbers with extensive cross-linking that are synthesized by adult
dermal ﬁbroblasts (Longaker et al., 1990b; Whitby and Ferguson,
1991a). Scarless repair is associated with such reticular deposition
of collagen types-I and -III leading to regeneration of dermal tis-
sue that is indistinguishable from adjacent non-wounded dermis,
while scar formation is characterized by the deposition of disor-
ganized collagen ﬁbers and the absence of epidermal appendages
(Lorenz et al., 1995). These differences in cellular and extracellular
factors inﬂuencing fetal and adult wound healing are highlighted
in Table 3.
In addition to differences in collagen and adhesion molecule
expression relative to adult wounds, fetal dermis and wounds are
also rich in glycosaminoglycans, especially hyaluronic acid (HA).
HA is a large hydroscopic molecule composed of alternating units
of glucuronic acid and N-acetylglucosamine and has the ability to
expand 1000 to 10,000 times its own volume by imbibing water
which facilitates hydration of the ECM (Bullard et al., 2003): a
matrix rich in HA is loose and permissive for cell adhesion, pro-
liferation and migration. HA also acts as a growth factor ‘sink’
by binding various growth factors and cytokines, thereby mod-
ulating the temporal and spatial presentation of these factors to
ﬁbroblasts. Relative to their adult counterparts, fetal ﬁbroblasts
(rabbit/human) produce more HA, have 2–4 fold higher expres-
sion of HA receptors and produce greater amounts of HA synthases
(Alaish et al., 1994; Kennedy et al., 2000). In vitro, fetal rabbit
ﬁbroblasts cultured in the presence of HA proliferate less and pro-
duce higher levels of collagenous and non-collagenous proteins
(Mast et al., 1993), which may  be especially relevant considering
that in vivo, HA remains in the fetal lamb wound bed for longer
periods than in adult wounds (Longaker et al., 1990a, 1991). HA
may  also be involved in the progressive loss of scarless healing abil-
ity with increasing gestational age; in fetal lamb wound ﬂuid, the
levels of HA and HA-stimulating activity reduce signiﬁcantly during
the transition period from fetal-type to adult-type wound healing
(Estes et al., 1993). Additionally, the total HA content of fetal skin
496 G. Sriram et al. / European Journal of C
Table 3
Comparison of factors inﬂuencing fetal and adult wound healing.
Fetal wound healing Adult wound healing
Extracellular matrix
Collagen Fine, reticular or
basket-weave pattern;
lower cross-linking
Thick; dense parallel
bundles or
disorganized; higher
cross-linking
Collagen type I: type
III (ratio)
Low High
Collagen deposition
(rate)
Immediate Delayed
Hyaluronan and
GAGs
Higher and persistent
expression of HA and
HA-receptor (CD44);
higher molecular
weight HA; high HASA;
more nonsulfated
GAGs
Lower and transient
expression of HA and
HA-receptor (CD44);
lower molecular
weight HA; low HASA;
more sulfated GAGs
Tenascin-C More; early deposition Low; late deposition
Decorin Low High
Fibromodulin High Low
Fibronectin More; early deposition Low; late deposition
Cellular factors
Epithelization Rapid Slow
Fibroblast Faster migration Slower migration
Myoﬁbroblasts Low and transient
appearance during
early wound phase
High and persistent
(especially larger
wounds)
Stem cells High Low
Inﬂammation
Response Minimal Higher levels
(leucocytes,
macrophasges, mast
cells)
Cytokines and
chemokines
Lower levels of
pro-inﬂammatory (IL6,
IL8); Higher levels of
anti-inﬂammatory
(IL10); low levels of
COX-2 and PGE2
Higher levels of
pro-inﬂammatory (IL6,
IL8); Lower levels of
anti-inﬂammatory
(IL10)
Growth factors
TGF-1 Low levels; transient High levels; prolonged
presence
TGF-3 Higher levels; quick
and prolonged
expression
Delayed expression
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HOX2—cycloygenase-2; GAGs—glycosaminoglycans; HA—hyaluronic acid;
ASA—hyaluronic acid stimulating activity; IL—interleukins; PGE2—prostaglandin-
2; TGF-—transforming growth factor-.
educes with increasing fetal age, and this process is temporally
inked with the appearance of other glycosaminoglycans, especially
ecorin and heparin sulphate (Estes et al., 1993). These temporal
hanges in the distribution of HA and other glycosaminoglycans
eﬂects the change from a fetal to an adult-like phenotype of the
CM that plays an important role in scarless repair of fetal skin
ounds mediated by fetal ﬁbroblasts across a range of mammalian
pecies.
More recently, the potential to use fetal ﬁbroblasts in engi-
eered skin substitutes has begun to be explored, and has shown
ome promise. Dermal matrices self-assembled by early human
etal ﬁbroblasts in vitro resemble a mid-gestational fetal dermis
n terms of various morphological and biochemical parameters
ncluding amount of collagen and HA (Pouyani et al., 2012). Further-
ore, gene expression array analysis of fetal and neonatal dermal
atrices, shows lower expression of genes associated with ﬁbrosis
nd higher expression of genes associated with anti-ﬁbrosis in fetal
broblast compared to neonatal ﬁbroblast-derived dermal matrix
Pouyani et al., 2012). Given the abundance of HA within the fetal
ermis and fetal wounds, several studies have explored the use
f HA-rich matrices in organotypic skin models: using esteriﬁed
A ﬁbers and ﬁbrin gels with ﬁbroblasts as a dermal equivalent,ell Biology 94 (2015) 483–512
Boukamp and colleagues demonstrated superior dermal and epi-
dermal architecture and long-term stability of the full-thickness
organotypic skin cultured for over 12 weeks relative to conven-
tional collagen-based dermal equivalents (Boehnke et al., 2007;
Mufﬂer et al., 2008; Stark et al., 2004b, 2006). The ﬁbroblasts within
the above HA-ﬁbrin based model also secrete a provisional matrix
consisting of ﬁbronectin and tenascin that progressively generated
organized collagen types-I and -III during the culture period, resem-
bling mature dermis.
Hence, a number of unique factors within the fetal microenvi-
ronment, in particular fetal ﬁbroblasts and the surrounding ECM
seem to contribute to scarless healing. Better understanding of
the mechanisms that underlie the scarless fetal wound healing,
has fueled an intensive research on altering the cascade of events
that accompany wound healing. Translating such knowledge could
provide immense opportunities in developing better skin equiva-
lents for basic research and clinical therapeutic endeavors.
5.2. Roles of ﬁbroblasts in scarless healing of the oral mucosa
Although dermal and oral mucosal wounds heal through similar
stages of hemostasis, inﬂammation, proliferation, and remodeling,
oral mucosal wounds tend to heal at a faster pace and, similar to
fetal wounds, display no or minimal scarring (Szpaderska et al.,
2003, 2005). While both oral and dermal ﬁbroblast sub-populations
are part of the greater adult ﬁbroblast compartment, they exhibit
signiﬁcant phenotypic and functional differences that contribute
to the differential healing outcomes observed in these sites. Of
note, oral mucosal ﬁbroblasts originate from the embryonic neural
crest and dermal ﬁbroblasts from the mesoderm (Xu et al., 2013);
a difference that is carried into the adult by means of distinct
expression proﬁles of the embryonic pattern-related HOX  genes
in the two  populations (Chang et al., 2002; Ebisawa et al., 2011).
Recently, Rinkevich et al. (2015), demonstrated the persistence of
two distinct embryonic ﬁbroblast traits: Wnt1-positive and neg-
ative (Wnt1+/Wnt1−) ﬁbroblasts in oral mucosa, and En1+/En1−
ﬁbroblasts in dorsal skin of adult mice. Both Wnt1+ and En1+ ﬁbro-
blast lineage contribute to the bulk of ECM deposition in the oral
mucosa and skin, respectively. However, reciprocal transplantation
of Wnt1+ and En1+ ﬁbroblasts into skin and oral mucosa, respec-
tively, show signiﬁcantly different scar architecture and reduced
scarring by Wnt1+ compared to En1+ ﬁbroblasts. These ﬁndings
indicate the site-speciﬁc differences in oral and dermal wound
healing, are due to cell-intrinsic differences rather than the local
environment.
Apparently the ﬁbroblast population of the adult oral mucosa
has more in common with fetal ﬁbroblasts than with their der-
mal  counterparts: human oral mucosal ﬁbroblasts proliferate more,
repopulate wounds more rapidly and are “replicatively younger”
than dermal ﬁbroblasts (Enoch et al., 2009, 2010; Mah  et al., 2014).
In addition to differences in the phenotype of the ﬁbroblasts, dif-
ferences in ECM and ECM-modulating factors also play a role in the
scarless healing of oral wounds. Cultured oral mucosal ﬁbroblasts
express higher levels of MMP-2 and MMP-3, and correspondingly
lower levels of their antagonists, TIMP-1 and TIMP-2, compared to
dermal ﬁbroblasts (Enoch et al., 2010; Mah  et al., 2014; McKeown
et al., 2007; Stephens et al., 2001a). The high ratio of MMPs to TIMPs
in oral mucosal wounds is comparable to that in early gestational
wounds (Dang et al., 2003a). Tenascin-C is an important regulator
of cell proliferation and migration during wound healing and its
basal level of expression is markedly higher in oral palatal mucosa
than in skin; wounding of the mammalian oral mucosa leads to
prolonged tenascin-C expression, similar to fetal wounds (Whitby
et al., 1991; Wong et al., 2009). Hence, an increased and prolonged
expression of tenascin-C may  play a role in accelerated wound heal-
ing. Another ECM molecule that plays a role in wound healing is
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A, the synthesis of which being dependent on the activity of the
ifferent isoforms of hyaluronan synthase (HAS). High-molecular
eight HA is synthesized with the aid of HAS-1 and HAS-2 iso-
orms, while HAS-3 isoform synthesize low-molecular weight HA.
n contrast to dermal ﬁbroblasts, human oral ﬁbroblasts exhibit dif-
erential expression of HAS subtypes and production of HA (Yamada
t al., 2004). Exposure of cultured human oral mucosal ﬁbroblasts
o IL-1 or epidermal growth factor (EGF) results in expression of
AS-3 transcripts, while dermal ﬁbroblasts express HAS-1 tran-
cripts (Yamada et al., 2004). Similarly, in vitro exposure to TGF1
esults in induction of HAS-1 expression in dermal ﬁbroblasts
ut not in oral mucosal ﬁbroblasts (Meran et al., 2007). Though
oth the ﬁbroblast subtypes express HAS-2 isoforms, exposure to
GF1 upregulates HAS-2 expression in dermal ﬁbroblasts, while
he human oral ﬁbroblasts display a down-regulation (Meran et al.,
007). These ﬁndings suggest the appropriate expression of HAS
soforms and the synthesis of appropriate HA molecules might play
 role in the wound healing response and in skin tissue engineering.
In addition to differences in ECM remodeling, oral mucosal ﬁbro-
lasts display differences in production and response to various
rowth factors and cytokines. For instance, cultured oral mucosal
broblasts express signiﬁcantly higher amounts of KGF and HGF
Okazaki et al., 2002; Shannon et al., 2006; Stephens et al., 2001b).
he multifunctional cytokine TGF isoforms play a pivotal role in
ound healing through its effect on ﬁbroblasts. In contrast to der-
al  wounds, oral mucosal wounds exhibit signiﬁcantly lower levels
f proﬁbrotic TGF1 and higher levels of antiﬁbrotic TGF3 (Eslami
t al., 2009; McKeown et al., 2007). Interestingly, TGF3 persists for
 prolonged period in oral mucosal wounds, and TGF1 suppresses
roliferation of oral ﬁbroblasts while it activates proliferation of
ermal ﬁbroblasts in vitro (Meran et al., 2008). Additionally, cul-
ured human oral ﬁbroblasts express less -SMA upon stimulation
ith TGF1 compared to dermal ﬁbroblasts (Lygoe et al., 2007;
eran et al., 2007), indicating lower responsiveness of oral ﬁbro-
lasts to TGF1 that favors a scarless healing. In vitro studies
emonstrate that oral mucosal ﬁbroblasts produce lesser contrac-
ion of collagen gels compared to dermal ﬁbroblasts both in the
resence or absence of TGF1; but the contraction occurs earlier
n the presence of oral mucosal ﬁbroblasts similar to fetal ﬁbro-
lasts (Lee and Eun, 1999; McKeown et al., 2007; Shannon et al.,
006). Secondly, the contractile ability of the oral and fetal ﬁbro-
lasts exists in spite the absence of -SMA expression. The lower
ontractile potency of oral ﬁbroblasts may  be one of the factors
hat can explain the faster healing with lower propensity for scar
ormation in oral wounds. Hence, the ratio of TGF3 to TGF1 and
he response of the ﬁbroblasts to TGF1 could be used as screening
riteria to select different ﬁbroblast phenotypes and also as a pre-
ictive tool for contraction of ﬁbroblasts populated collagen-based
rganotypic cultures of skin.
Organotypic oral mucosa models have been developed using
ocultures of oral mucosal ﬁbroblasts and oral keratinocytes on
arious dermal scaffolds and de-epidermized mucosa (Costea
t al., 2003, 2005; Dongari-Bagtzoglou and Kashleva, 2006;
riegebaum et al., 2012; Lukandu et al., 2010; MacNeil et al., 2011;
oharamzadeh et al., 2012). Similar to in vivo heterotopic recom-
ination studies described earlier, in vitro homotypic organotypic
ultures using human ﬁbroblasts and keratinocytes from skin
nd oral mucosa show the resemblance of engineered homotypic
pithelial tissues to parent tissues (skin/oral mucosa), but the hete-
otypic cultures of oral ﬁbroblasts and skin keratinocytes resulted
n formation of epithelium similar to oral mucosa (Chinnathambi
t al., 2003). While the fetal-like phenotype and high accessibil-
ty of oral mucosal ﬁbroblasts (as opposed to restricted access
o fetal ﬁbroblasts) are attractive for tissue engineering purposes,
he inherent epigenetic memory within these ﬁbroblasts precludes
heir use for skin tissue engineering. However, the insights learntell Biology 94 (2015) 483–512 497
from the phenotype of oral ﬁbroblasts could be used to select
or genetically engineer dermal ﬁbroblasts favorable for superior
organotypic skin cultures. Secondly, deeper understanding of the
potential mechanisms contributing to the scarless phenotype of
oral mucosal wounds is needed to understand the mechanisms
operating in the dermal and oral wounds.
5.3. Involvement of ﬁbroblasts in keloids and hypertrophic
scarring
While fetal and oral mucosal wounds exist at one end of the
wound healing spectrum, hypertrophic scars and keloids repre-
sent the other end: these pathological scarring conditions occur
due to an aberrant ﬁbroblastic response following a cutaneous
injury. The scars themselves are characterized by hyperprolifer-
ation of the resident wound ﬁbroblasts, excessive ECM production
(especially collagen type-I), persistence of myoﬁbroblasts, and
increased expression of -SMA and various cytokines including
TGF1 (Jumper et al., 2015; Lee et al., 2004). Histopathology reveals
that the arrangement of ﬁbroblasts and the deposition of collagen
are haphazard in these lesions (Lee et al., 2004).
Both genetic and environmental factors are involved in sus-
ceptibility to pathological scarring, but it has been proposed that
abnormalities in epidermal-dermal crosstalk at the wound site
also play a role. Lesional keratinocytes and ﬁbroblasts are signif-
icantly different in comparison to non-lesional skin; keloid and
hypertrophic scar ﬁbroblasts express higher levels of -SMA in situ
(Ehrlich et al., 1994; Machesney et al., 1998), while lesional kerati-
nocytes in the basal layer of the epidermis show higher expression
of activin-A and follistatin (Mukhopadhyay et al., 2007). More-
over, lesional keratinocytes seem to be in a prolonged state of
activation, indicated by expression of K6, K16 and K17, which
is accompanied by premature expression of ﬁlaggrin (Machesney
et al., 1998). Similar differences in the phenotypes of lesional and
non-lesional ﬁbroblasts and keratinocytes are also observed in vitro
and are therefore relatively well-deﬁned. Compared to normal
ﬁbroblasts, keloid-derived ﬁbroblasts in monolayer cultures show
increased expression of collagen type I, activin-A, follistatin, -
SMA, thrombospondin, and matrix remodeling factors including
MMP-1 and -2, and TIMP1 (Chipev et al., 2000; Fujiwara et al., 2005;
Mukhopadhyay et al., 2007; Phan et al., 2002). Studies suggests that
the cytokine TGF1 plays a role in regulating the production of ECM
and ECM remodeling factors (Fujiwara et al., 2005), and accord-
ingly, the addition of neutralizing anti-TGF antibodies to cultures
can partially revert the phenotype of keloid ﬁbroblasts (Younai
et al., 1996). Compared to cultures derived from normal skin, cocul-
tures of keratinocytes and ﬁbroblasts from keloids exhibit higher
expression of TGF1, TGF3 and TGF receptor 1 in the keratino-
cytes, associated with higher expression of TGF1, TGF2, TGF
receptor 1 and Smad2 by ﬁbroblasts (Xia et al., 2004). Studies have
also indicated the roles of keloid/hypertrophic scar keratinocyte-
derived growth factors, including platelet-derived growth factor
and insulin-like growth factors, in driving the proliferation of der-
mal  ﬁbroblasts and synthesis of dermal matrix components that
lead to scar formation (Funayama et al., 2003; Lim et al., 2001,
2002; Mukhopadhyay et al., 2005; Niessen et al., 2001; Phan et al.,
2002, 2003a; Robb et al., 1987). However, various questions like
the key events involved in aberrant change in the normal wound
healing mechanisms, the timing of these events, factors that trigger
the phenotypic switch, factors that drive or maintain the activated
state of ﬁbroblasts, why certain areas of the body are more suscep-
tible, and the process that aid the extension of keloid scars beyond
the original wound margin are poorly understood.
The opioid receptor system is another important component in
epidermal homeostasis and wound healing (Bigliardi-Qi et al., 1999,
2000; Bigliardi and Bigliardi-Qi, 2014; Bigliardi et al., 1998, 2009).
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ypertrophic scar tissue as well as keratinocytes and ﬁbroblasts
ultured from hypertrophic scars express higher levels of all three
pioid receptors (mu-, delta- and kappa-, or MOPr, DOPr, KOPr)
han their counterparts in non-scarred skin (Cheng et al., 2008)
uggesting a link between the opioid receptor system and hyper-
rophic scars. Treatment of skin organ cultures from normal human
kin with -endorphin resulted in upregulation of TGF receptor
I and cytokeratin K16 in the epidermis (Bigliardi-Qi et al., 2000),
hich could be highly relevant in the case of hypertrophic scarring,
s discussed above. In vitro cell culture studies show that ectoderm-
erived cells (keratinocytes and melanocytes) express higher levels
f MOPr than DOPr, while the mesoderm-derived cells (ﬁbro-
lasts and dermal papilla) express higher levels of DOPr than MOPr
Bigliardi et al., 2009). We  have previously reported MOPr and DOPr
nockouts are associated with epidermal atrophy, thickening of the
pidermis at the wound edge and delayed wound healing response
Bigliardi-Qi et al., 2006, 2007); while KOPr knockout mice exhibit
pidermis of normal thickness (Bigliardi-Qi et al., 2007) suggest-
ng a role of the opioid receptor system for keratinocyte migration
nd differentiation. Organotypic cultures of DOPr-overexpressing
/TERT-1 cells develop an atrophic epithelium lacking keratin 10
xpression (marker of early differentiation) compared to controls
uggesting the role of DOPr on epidermal homeostasis and regen-
ration (Neumann et al., 2015). Though the role of opioid receptors
n keratinocytes has become to be acknowledged, their role in
ifferent populations of dermal ﬁbroblasts and in hypertrophic
cars/keloids has yet to be probed.
As few animal models of hypertrophic scarring and keloids are
vailable (Estrem et al., 1987; Wang et al., 2011; Zhu et al., 2003),
he organotypic coculture model is a valuable tool in dissecting
he pathogenesis underlying these scars. Butler et al. observed
ncreased collagen deposition, denser organization of -SMA ﬁbers,
nd greater dermal contracture in organotypic skin cultures derived
rom keloid ﬁbroblasts and keratinocytes compared to those from
ormal skin (Butler et al., 2008; Chiu et al., 2005). Moreover, lesional
broblasts demonstrated increased contraction of both ﬁbrin and
ollagen gels (Phan et al., 2003b; Younai et al., 1996) indicating a
ore contractile phenotype of keloid ﬁbroblasts. Further, cultured
eloid ﬁbroblasts seem to generate higher amounts of intracellular
hotosensitizer (protoporphyrin IX) and reactive oxygen species,
nd revealed higher cytotoxicity compared to normal ﬁbroblasts
fter photodynamic therapy and electrical stimulation (Sebastian
t al., 2011). Thus organotypic cultures have also been used to
omprehend the effects of treatments on scarred skin (Chiu et al.,
005; Lee et al., 2013). Exposure of cocultures of neonatal, adult
nd keloid-derived ﬁbroblasts and keratinocytes to various doses
f photodynamic therapy revealed that keloid ﬁbroblasts respond
ifferently than those from normal skin (Chiu et al., 2005). Further-
ore, recent investigations suggest the existence of heterogeneity
mong ﬁbroblasts within the keloid lesion. A recent study engrafted
rganotypic skin derived from keloid keratinocytes and ﬁbroblasts
nto athymic mice, and found differences in scar characteristics
etween superﬁcial and deep keloid-ﬁbroblasts (Supp et al., 2012).
he authors hypothesized that the superﬁcial (papillary) and deep
reticular) keloid ﬁbroblasts contribute differentially towards the
ormation of the scar tissue. Deep keloid ﬁbroblasts are proposed
o cause thickening of the scar due to an imbalance between ECM
roduction and degradation, while the superﬁcial keloid ﬁbroblasts
lay a role in increasing the surface area of the scar tissue. These
eloid ﬁbroblast phenotypes are not only heterogeneous in terms
f their functional role and response to cytokines or growth factors,
ut also to immunomodulatory (Russell et al., 1995) and photody-
amic (Mendoza et al., 2012) therapies. Keloid ﬁbroblasts seem to
ifferentially respond to photodynamic therapy depending on the
ocation of the ﬁbroblasts within the lesion (Mendoza et al., 2012).
n this study, the authors demonstrated that keloid ﬁbroblasts fromell Biology 94 (2015) 483–512
the core of the keloid lesion displayed higher cytotoxicity to pho-
todynamic therapy compared to those from superﬁcial dermis and
margins of the lesion suggesting a site-targeted therapy.
In addition to intrinsic differences in the ﬁbroblast phenotypes,
the local microenvironment in particular the composition of the
ECM, may  modulate ﬁbroblast behavior. For instance, in the deeper
dermis the ECM contains lower levels of anti-ﬁbrotic molecules
such as decorin and ﬁbromodulin compared to the superﬁcial
dermis (Honardoust et al., 2011, 2012a,b; Varkey et al., 2011).
Hence, both heterogeneity in the ﬁbroblast subpopulations and
their microenvironment play an important role in the pathogenesis
of keloids and hypertrophic scars. From a skin tissue engineering
point of view, appropriate expression of ﬁbrotic and anti-ﬁbrotic
factors by the ﬁbroblasts and the surrounding ECM (i.e.,  dermal
equivalent) should be given due consideration.
6. Fibroblasts in engineered medical skin replacements
Ideal tissue engineered skin replacements for clinical use must
be able to support complete reconstruction of physiological skin
without any scar tissue, prevent ﬂuid and heat loss, be non-
toxic, biocompatible, free of pathogens, must lack immunogenicity,
provide a barrier to micro-organisms and lack the potential for
tumorogenecity. Yet they have to be cost-effective, easily available,
user-friendly and have long shelf life (MacNeil, 2007). In addition to
restoration of epidermal and dermal layers, complete reconstruc-
tion of various anatomical aspects of skin includes reinstitution of
skin pigmentation, adnexal structures, vascularity, and innervation.
A number of strategies have been explored in the past few decades
to achieve the goals of skin tissue engineering that are excellently
reviewed elsewhere (Kamel et al., 2013; Metcalfe and Ferguson,
2007; Shevchenko et al., 2010). Currently, split-thickness autolo-
gous skin grafts are considered the gold-standard for treatment of
full-thickness dermal injuries (Adzick and Longaker, 1991). These
skin grafts consist of epidermis and a superﬁcial part of the der-
mis  harvested using a dermatome from undamaged, healthy donor
site (undamaged, healthy area). Various skin equivalents are com-
mercially available for treatment of skin loss which are classiﬁed as
acellular or cellular; biological (autologous, allogeneic, xenogeneic)
or synthetic (biodegradable, non-biodegradable); epidermal, der-
mal  or dermo-epidermal (full-thickness) skin substitutes (listed
in Tables 4–6) and are excellently reviewed elsewhere (MacNeil,
2007; Patel and Fisher, 2008; Shevchenko et al., 2010). Currently,
dermo-epidermal skin substitutes are the most advanced and
sophisticated skin replacement that consist of allogeneic keratino-
cytes seeded onto a dermal scaffold with or without ﬁbroblasts. In
spite of the presence of both the dermal and epidermal compart-
ments, these skin substitutes act as temporary wound dressings
that are biologically active through the provision of cells, growth
factors, cytokines and ECM that aids the recruitment of host cells
and eventually healing of the wound area (Supp and Boyce, 2005).
The vast variety of skin substitutes available on the market has
contributed to the improvement in the management of burns,
chronic dermal wounds, immunological and congenital skin dis-
orders. However, none of the currently available skin substitutes
fulﬁll all the above-mentioned criteria nor are they capable of
replacing all the anatomical and functional properties of the native
skin (Shevchenko et al., 2010).
Various challenges regarding the clinical use of existing com-
mercially available skin substitutes include issues related to
scarring, deﬁcient vascularization, absence of adnexal structures of
the skin, delay during the cell culture process, allogeneic cell source,
immunogenicity, mechanical and handling properties, safety issues
and high production costs (Metcalfe and Ferguson, 2007). Scar-
ring is one of main clinical challenges that may  involve the whole
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Table  4
Commercially available epidermal equivalents for clinical applications.
Brand name Manufacturer Cells Cell source Cell
seeding
Scaffold
material
Advantages Disadvantages
Bioseed-S BioTissue
Technlogies
(Germany)
Subconﬂuent
suspension of
cultured
keratinocytes
Autologous in vitro Fibrin
sealant
Permanent, better
handling, improved
cell attachment,
haemostasis and
wound healing.
Little risk of
rejection
Long culture time,
limited to
partial-thickness
wounds
CellSpray Clinical Cell
Culture (C3,
Australia)
Subconﬂuent
suspension of
cultured
keratinocytes
Autologous in vitro – Reduced culture
time, better
handling,
permanent, little
risk of rejection
Limited to
partial-thickness
wounds
EPIBASE Laboratories
Genevrier
(France)
Conﬂuent sheet
of cultured
keratinocytes
Autologous in vitro –
Epicel Genzyme
Biosurgery
(USA)
Conﬂuent sheet
of cultured
keratinocytes
Autologous in vitro – Permanent, large
area of wound
coverage, little risk
of rejection
Long culture time
(atleast 3 weeks),
fragile conﬂuent
sheets, susceptible
to blistering
(post-grafting)
Epidex Modex
Therapeutics
(Switzerland)
Conﬂuent sheet
of cultured
keratinocytes
Autologous;
from outer
root sheath
of scalp hair
follicles
in vitro – Permanent, little
risk of rejection,
higher proliferative
capacity. Can be
cryopreserved for
repeat applications
Long culture time
(atleast 5–6
weeks), fragile
conﬂuent sheets
Laserskin or
Vivoderm
Fidia Advanced
Biopolymers
(Italy)
(Convatec)
Conﬂuent sheet
of cultured
keratinocytes
Autologous in vitro Recombinant
hyaluronic
acid
membrane
Less fragile
delivery system,
Hyaluronic acid
improves
mechanical
stability, little risk
of rejection
Long culture time
(atleast 3 weeks)
MySkin  CellTran Ltd
(UK)
Subconﬂuent
sheet of
cultured
keratinocytes
Autologous in vitro Silicone
support
layer with
a  plasma-
polymerized
surface
Silicone support
layer encourages
keratinocyte
attachment and
proliferation.
Improved and
stable delivery
Long culture time
(atleast 2 weeks).
Repeated
application
required for
optimal clinical
outcome
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oeplaced tissue and/or the graft margins which in turn results in
 skin that is functionally, mechanically and/or esthetically infe-
ior to native skin. Additionally, scar tissue is not amenable for
egeneration of skin appendages. To address this problem, the next
eneration skin substitutes should possess structural and func-
ional properties of native skin and anti-scarring strategies should
id the integration with the host tissue without any scarring.
As previously discussed ﬁbroblasts and their surrounding ECM
lay an important role in the scarring process. Fibroblasts currently
n use for engineering skin tissue replacements are: autologous
r allogeneic, primary cells or progenitors. Autologous ﬁbroblasts
re advantageous as they lack risk of rejection and cross contami-
ation with blood-borne and/or xenogeneic pathogens. However,
hey are not readily available and may  not be available in sufﬁ-
ient cell numbers especially at old age and from patients with
xtensive burns. In contrast, allogeneic cells could be obtained
rom young donors, expanded in culture to sufﬁcient quantities,
ryopreserved and thus amenable for off-the-shelf availability.
arly studies comparing dermal substitutes populated with autolo-
ous or allogeneic ﬁbroblasts revealed better restoration of dermis
ith minimal scar formation when autologous ﬁbroblasts are used
Lamme  et al., 2002; Morimoto et al., 2005). Studies on immuno-
ogical tolerance of allogeneic cells on the recipient and survival
f donor cells in the host show varying ﬁndings. In a short-termplatform. Can be
cryopreserved for
repeat applications
study on guinea pig (Morimoto et al., 2005) survival of allogeneic
ﬁbroblasts was found in the host up to three-weeks, while stud-
ies in pig (Price et al., 2004) and humans (Kolokol’chikova et al.,
2001) reported absence of allogeneic ﬁbroblasts after 1 week. Cer-
tain long-term studies demonstrate the presence of proliferating
allogeneic ﬁbroblasts and host immunogenic tolerance up to two
months (Eaglstein et al., 1999; Grifﬁths et al., 2004; Hebda and
Dohar, 1999; Sandulache et al., 2003). In contrast, clinical studies
using a bilayered skin substitute composed of allogeneic keratino-
cytes and ﬁbroblasts in a collagen gel demonstrated the absence
of DNA of donor cells beyond 4–6 weeks (Grifﬁths et al., 2004; Hu
et al., 2006; Phillips et al., 2002). These clinical studies also did
not reveal any evidence of immunological rejection of the graft
which is believed to be due to lack of expression of major histocom-
patibility complex (MHC-class II) antigens (Theobald et al., 1993)
and absence of antigen-presenting cells like Langerhan’s cells fol-
lowing serial passages of allogeneic ﬁbroblasts and keratinocytes
(Phillips et al., 2002). Further, clinical studies demonstrate that
allogeneic ﬁbroblast populated dermal substitutes with or with-
out keratinocytes in chronic venous ulcers, diabetic foot ulcers and
pressure ulcers result in signiﬁcant healing compared to conven-
tional treatment alone (Brem et al., 2000; Falanga et al., 1998; Jones
and Nelson, 2005; Marston et al., 2003). These studies demonstrate
the immunological safety in using allogeneic ﬁbroblasts and their
500
 
G
.
 Sriram
 et
 al.
 /
 European
 Journal
 of
 Cell
 Biology
 94
 (2015)
 483–512
Table 5
Commercially available dermal equivalents for clinical applications.
Brand name Manufacturer Cells Cell source Cell
seeding
Scaffold material Advantages Disadvantages
Alloderm LifeCell Corporation (USA) – – in vivo Allogeneic; Human acellular
lyophilized dermis
Permanent; Preserved native human
ECM; Reduced antigenic components
due to processing; Off-the-shelf
Potential risk of disease
transmission
Allopatch HD Conmed (USA) – – in vivo Allogeneic; Human acellular
dermis
Permanent; Preserved native human
ECM; Reduced antigenic components
due to processing; Off-the-shelf
Potential risk of disease
transmission
AlloSkin RT AlloSource (USA) – – in vivo Allogeneic; Human acellular
dermis (irradiated); Meshed
Preserved native human ECM; Reduced
antigenic components due to
processing; Room temperature
storage; Pliable and stretchable;
Off-the-shelf
Potential risk of disease
transmission
Cortiva
Allograft
Dermis
RTI  Surgical (USA) – – in vivo Allogeneic; Human
non-crosslinked, acellular
dermis (irradiated)
Preserved native human ECM; Reduced
antigenic components due to
processing; Room temperature
storage; Off-the-shelf
Potential risk of disease
transmission
DermACELL LifeNet Health (USA) – – in vivo Allogeneic; Human acellular
dermis
Preserved native human ECM; Reduced
antigenic components due to
processing; Room temperature
storage; Off-the-shelf
Potential risk of disease
transmission
Dermagraft Organogenesis Inc (USA)
(Advanced BioHealing Inc,
USA)
Cultured
Human
dermal
ﬁbroblasts
Allogeneic in vitro ECM-coated polyglactin mesh;
ECM derived from cultured
human dermal ﬁbroblasts
ECM components and growth factors
secreted by ﬁbroblasts aid wound
healing; Bioabsorbable
Potential risk of disease
transmission; Temporary
Flex  HD Ethicon (USA) – – in vitro Allogeneic; Human acellular
dermis
Reduced antigenic components due to
processing; Room temperature
storage; Off-the-shelf
Potential risk of disease
transmission
Fortiva  Porcine
Dermis
RTI Surgical (USA) - - in vivo Xenogeneic; Porcine
non-crosslinked acellular
dermis
Preserved native ECM; Reduced
antigenic components due to
processing; Room temperature
storage; Off-the-shelf
Potential risk of disease
transmission
GammaGraft Promethean LifeSciences Inc.
(USA)
– – in vivo Allogeneic; Human acellular
dermis (irradiated)
Preserved native human ECM; Reduced
antigenic components due to
processing; Room temperature
storage; Pliable and stretchable;
Off-the-shelf.
Potential risk of disease
transmission
GraftJacket Wright Medical Technology
(USA)
– – in vivo Allogeneic; Human acellular
meshed lyophilized dermis
Permanent; Preserved native human
ECM; Reduced antigenic components
due to processing; Convenient
application as it is pre-meshed;
Successful in full-thickness wounds;
Off-the-shelf.
Potential risk of disease
transmission
Hyalomatrix
PA/Hyaloﬁll
Anika  Therapeutics (USA)
(Fidia Advanced Biopolymers,
Italy)
– – in vivo Synthetic; Hyaluronic
acid-based
Semi-permanent; No animal or
allogeneic human-derived components
–
Integra  Dermal
Regeneration
Template
Integra NeuroSciences (USA) – – in vivo Xenogeneic and synthetic
(Polysiloxane); Bovine
cross-linked collagen and
glycosaminoglycans
Semi-permanent (epidermal
equivalent replaced with autograft
after 2 weeks); Polysiloxane
membrane controls bacterial
contamination and water loss;
Encourages ﬁbroblast and keratinocyte
ingrowth; Off-the-shelf
Bovine origin; Potential risk of
disease transmission; Longer
time (∼3 weeks) required for
expanding dermal autograft
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Matriderm MedSkin Solutions Dr
Suwelack AG (Germany)
– – in vivo Xenogeneic; Bovine acellular
lyophilized dermis (coated
with -elastin hydrolysate)
Permanent; Preserved native collagen
matrix; Reduced antigenic components
due to processing; Successful in
full-thickness burns; Off-the-shelf
Bovine origin; Potential risk of
disease transmission
Matrix  HD/
Matrix HD
Fenestrated
RTI Surgical (USA) – – in vivo Allogeneic; Human acellular
dermis; Meshed (Fenestrated)
Preserved native human ECM; Reduced
antigenic components due to
processing; Room temperature
storage; Off-the-shelf
Potential risk of disease
transmission
MemoDerm Memometal Inc. (USA) – – in vivo Allogeneic; Human acellular
dermis (irradiated)
Preserved native human ECM; Reduced
antigenic components due to
processing; Room temperature
storage; Off-the-shelf
Potential risk of disease
transmission
OASIS  Wound
Matrix
Cook Biotech Inc – – in vivo Xenogeneic; Porcine acellular
lyophilized submucosa of small
intestine
Permanent; Preserved native collagen
matrix; Reduced antigenic components
due to processing; Off-the-shelf
Porcine origin; Potential risk of
disease transmission
Pelnac
(Standard/
Fortiﬁed)
Gunze Ltd. (Japan) – – in vivo Xenogeneic and synthetic
(silicone membrane); Porcine
lyophilized cross-linked
collagen
Semi-permanent; Silicone membrane
controls bacterial contamination and
water loss; Long shelf life; Off-the-shelf
Porcine origin; Potential risk of
disease transmission;
Insufﬁcient revascularization
Permacol Covidien (UK) (Tissue Science
Laboratories, UK)
– – in vivo Xenogeneic; Porcine acellular
diisocyanite cross-linked
dermal matrix
Permanent; Reduced antigenic
components due to processing;
Off-the-shelf
Porcine origin; Potential risk of
disease transmission
ProHeal MedSkin Solutions Dr
Suwelack AG (Germany)
– – in vivo Xenogeneic; Bovine acellular
native collagen
Permanent; Preserved native collagen
matrix; Reduced antigenic components
due to processing; Successful in
full-thickness burns; Off-the-shelf.
Bovine origin; Potential risk of
disease transmission.
Puros  Dermis Zimmer Dental (USA) – – in vivo Allogeneic; Human acellular
dermis (irradiated)
Preserved native human ECM; Reduced
antigenic components due to
processing; Room temperature
storage; Off-the-shelf
Potential risk of disease
transmission
SureDerm Hans Biomed Corporation
(Korea)
– – in vivo Allogeneic; Human acellular
lyophilized dermis
Permanent; Preserved native human
ECM; Reduced antigenic components
due to processing; Successful in
hypertrophic scar revision and burn
wounds; Off-the-shelf
Potential risk of disease
transmission; requires 10 min
rehydration before application
Terudermis Olympus Terumo Biomaterial
Corp., (Japan)
– – in vivo Xenogeneic and synthetic
(silicone membrane); Bovine
heat-denatured ﬁbrillar
atelocollagen
Semi-permanent; Silicone membrane
controls bacterial contamination and
water loss; Successful in treatment of
deep burns; Silicone membrane peels
off naturally; Off-the-shelf
Bovine origin; Potential risk of
disease transmission
Transcyte
(Dermagraft
TC)
Advanced Tissue Sciences
(USA) (Advanced BioHealing
Inc, USA)
Cultured
Human
dermal
ﬁbroblasts
Allogeneic in vitro ECM-coated nylon mesh; ECM
derived from cultured human
dermal ﬁbroblasts
ECM components and growth factors
secreted by ﬁbroblasts aid wound
healing
Allogeneic; Potential risk of
disease transmission;
Temporary; Nylon mesh is not
biodegradable
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Table 6
Dermo-epidermal composite skin equivalents for clinical applications.
Brand name Manufacturer Cells Cell source Cell
seeding
Scaffold material Advantages Disadvantages
AlloSkin AlloSource
(USA)
Keratinocytes,
ﬁbroblasts
Allogeneic;
Cadaveric;
Cryopreserved
-  Cadaveric human
skin; Meshed
Full thickness skin
graft; Delivers
ECM, components,
cytokines and
growth factor.
Potential risk of
disease
transmission
Apligraf  Organogenesis
Inc (USA)
Keratinocytes,
ﬁbroblasts
Allogeneic; Human
neonatal
foreskin-derived
in vitro Xenogeneic;
bovine type I
collagen
Full thickness skin
graft; Graft uptake
similar to
autografts; Delivers
ECM, components,
cytokines and
growth factors
Very short shelf life
(∼5 days);
Temporary
bioactive dressing;
needs delicate
handling; Potential
risk of disease
transmission; High
cost
ExpressGraft Stratatech
Corp.(USA)
Keratinocytes,
ﬁbroblasts
Allogeneic;
Keratinocytes:
Genetically
modiﬁed
immortalized
human
keratinocyte
progenitor cell line
(NIKS) Fibroblasts:
Human dermal
ﬁbroblasts
in vitro Type I collagen
(non-bovine)
(proprietary)
Full thickness skin
graft
Not commercially
available (Clinical
trial phase); use of
allogeneic,
genetically
modiﬁed,
immortalized cell
lines
OrCel  Forticell
Bioscience,
Inc.(USA)
(Ortec
Interna-
tional)
Keratinocytes,
ﬁbroblasts
Allogeneic; Human
neonatal
foreskin-derived
in vitro Xenogeneic;
bovine type I
collagen sponge
Full thickness skin
graft; Graft uptake
similar to
autografts; Delivers
ECM, components,
cytokines and
growth factors;
Cryopreserved
Needs delicate
handling; Potential
risk of disease
transmission; High
cost
PermaDerm Regenicin Keratinocytes,
ﬁbroblasts
Autologous in vitro Bovine type I
collagen
Full thickness skin
graft; Autologous
Not commercially
available (Clinical
trial phase); Long
culture time
PolyActive HC
Implants
BV
(Netherlands)
Keratinocytes,
ﬁbroblasts
Autologous in vitro Synthetic
PolyActive matrix
(polyethylene
oxide terephthalate
and polybutylene
terephthalate)
Full thickness skin
graft; Autologous
Not commercially
available (Clinical
trial phase); Long
culture time;
Primarily used for
bone
reconstruction;
non-biodegradable
StrataGraft Stratatech
Corp.(USA)
Keratinocytes,
ﬁbroblasts
Allogeneic;
Keratinocytes:
immortalized
human
keratinocyte
progenitor cell line
(NIKS) Fibroblasts:
Human dermal
ﬁbroblasts
in vitro Type I collagen
(non-bovine)
(proprietary)
Full thickness skin
graft
Not commercially
available (Clinical
trial phase); use of
allogeneic
immortalized cell
lines
TheraSkin Soulble
Systems
Keratinocytes,
ﬁbroblasts
Allogeneic;
Cadaveric;
–  Cadaveric human
skin; Meshed
Full thickness skin
graft; Delivers
Potential risk of
disease
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ole in wound healing in spite of their disappearance over a period
f few weeks. However, the wounds healed with formation of scar
issue indicating a suboptimal regeneration of the skin.
To modulate the scar tissue formation following grafting with
issue engineered skin substitutes various strategies have been
ursued. A study using porcine full-thickness wound model,
emonstrated improvement in wound healing and modulation of
car tissue with higher number of ﬁbroblasts present in the dermal
ubstitute at the moment of transplantation (Lamme  et al., 2000).
ased on the understanding of cellular and molecular mechanisms
f scarring and scarless fetal wounds, many companies are develop-
ng novel pharmaceutical compounds that prophylactically preventECM, components,
cytokines and
growth factors
transmission
scar formation (excellently reviewed elsewhere, Occleston et al.,
2008; Rhett et al., 2008). A promising pharmaceutical candidate
avotermin (recombinant human TGF3) for prevention of that was
developed based on the ﬁnding that scarless fetal and oral wounds
possess lower levels of proﬁbrotic factors (like TGF1, TGF2, and
PDGF) and higher levels of anti-ﬁbrotic molecules (like TGF3)
(Occleston et al., 2008, 2011). Though phase I/II trials were success-
ful, avotermin failed in phase III trials and is currently discontinued.
Similarly, another product based on recombinant human IL-10
(ilodecakin) for scar prevention was discontinued after phase II tri-
als. Studies investigating the development of novel skin substitutes
with appropriate combination of ﬁbroblasts and ECM that favor
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eig. 6. Flow chart schematically represents the development of organotypic skin 
pidermis models to complex full-thickness models. These full-thickness skin cultu
kin  culture models. Currently, these models are being miniaturized and incorporat
car-free healing and anti-ﬁbrotic strategies are needed to enhance
ntegration with the host tissue.
Similar to TGF signaling, differential expression and bal-
nce of FGF and VEGF isoforms and receptors are hypothesized
o play a role in scarless fetal wound healing (Colwell et al.,
005; Dang et al., 2003b). Studies demonstrate acceleration of
issue regeneration by a dermal substitute incorporated with
ollagen/gelatin-FGF2 microspheres through accelerated ﬁbroblast
roliferation and angiogenesis in a dose-dependent manner (Kanda
t al., 2012; Kawai et al., 2000). Delayed or insufﬁcient angiogen-
sis at the wound site play a role in chronic wounds, resulting
n delayed or failure of graft uptake in deep burns. A study on
brin-based dermal substitutes cultured with human ﬁbroblasts
nd keratinocytes demonstrated higher levels of VEGF secretion,
mproved regeneration of epidermal structures and migration of
ndothelial cells compared to collagen-based dermal substitutes
Hojo et al., 2003). Coculture experiments using dermal ﬁbroblasts
nd endothelial cells demonstrate that papillary ﬁbroblasts are
ore permissive for supporting differentiation of endothelial cells
ompared to reticular ﬁbroblasts (Sorrell et al., 2008). Delayed or
nsufﬁcient angiogenesis at the wound site play a role in chronic
ounds, and delayed or failure of graft uptake in deep burns.
ence, the phenotype of ﬁbroblasts at the wound bed may  play a
rucial role in wound healing. Engineering dermal-epidermal skin
ubstitutes with angiogenesis-permissive phenotype of ﬁbroblasts
ust be given due consideration. Recently, there are efforts at
ngineering vascularized skin equivalents using tri-culture of ﬁbro-
lasts, endothelial cells and keratinocytes (Black et al., 1998; Chan
t al., 2012; Marino et al., 2014). The phenotype of all these cells
ncluding ﬁbroblasts might need to be considered in the develop-
ent of next generation of skin equivalents.
Ultimate tissue engineering goal would be to combine variousrowth factors, cytokines, transcription factors, ECM components,
harmaceutical compounds and cells based on lessons learned
rom embryonic and adult wound healing to develop clinically rel-
vant novel skin substitutes for complete skin regeneration. Ines from a simple monolayer cultures to keratinocyte-based reconstructed human
dels gave birth to various skin disease, skin cancer, skin wound and more complex
o microﬂuidic chips for skin-on-chip and multi-organ chip platforms.
spite of growing evidence on ﬁbroblast heterogeneity and their
role in epidermal morphogenesis and wound healing, none of
the commercially available tissue engineered skin replacements
and clinical studies seem to have addressed it. A skin substi-
tute with optimal combination of dermal ﬁbroblasts and their
ECM reﬂecting the physiological heterogeneity of ﬁbroblast popu-
lations and their microenvironment is yet to be designed and
investigated. Hence, it would be imperative to investigate more
intensively the role of ﬁbroblast heterogeneity for clinical applica-
tions. Furthermore, the phenotypic differences within the wound
bed, differences in their behavior at different stages of the wound
healing and in different diseased states needs to be investigated
and taken into consideration in developing novel, therapeutic skin
replacements.
7. Concluding remarks
Use of increasingly complex in vitro models, in particular 3D
organotypic cultures mimicking features of the healthy and dis-
eased human skin represents a valuable tool. These organotypic
skin cultures have been used for the past three decades in the
ﬁeld of dermatology research that include basic research to under-
stand dermal-epidermal, cell–cell and cell–matrix interactions in
health and disease, as an in vitro tool to model healthy and diseased
states, for cosmetic and pharmaceutical drug development and
testing, and development of therapeutic skin replacement prod-
ucts. However, they have various short-comings that limit their
applications. For instance, shrinkage of the dermal matrix limits
their culture period and also their utility for basic and clinical
research. Hence, improvements in regard to the composition of
ECM of the dermal compartment, physical stability of the dermal
equivalent and ability for long term cultures are needed. Addition-
ally, the barrier properties of skin equivalents are inferior compared
to native skin as assessed by transcutaneous permeability assays
and composition of various lipid signatures within the stratum
corneum (Asbill et al., 2000; Godin and Touitou, 2007; Thakoersing
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t al., 2012, 2013). Native skin is composed of different ﬁbroblasts
henotypes that vary in terms of density, anatomic distribution and
unctional aspects. As dermal-epidermal interactions play a major
ole in epidermal morphogenesis, reconstruction of human skin
ith appropriate combination of different ﬁbroblast phenotypes
ithin the dermal compartment might result in engineering supe-
ior skin equivalents. In addition to the mere presence of ﬁbroblasts,
actors that play a role in epidermal morphogenesis include the
henotype of ﬁbroblasts, their density within different layers of the
ermal matrix, timing of ﬁbroblast pre-conditioning phase before
he addition of keratinocytes, use of post-mitotic ﬁbroblasts, age
f the donor, effect of environmental factors like ultraviolet light
nd probably the effect of other cell types including melanocytes,
ndothelial cells and hair follicle cells.
Generally, all ﬁbroblast phenotypes express an array of intra-
ellular and surface markers like vimentin, ﬁbroblast-speciﬁc
rotein-1 (FSP-1), CD90, CD73, CD44, CD13 (aminopeptidase N),
ersican, and -SMA (Sorrell and Caplan, 2009). However, these
arkers are not speciﬁc to ﬁbroblasts and hence, pose difﬁcul-
ies in isolation of ﬁbroblast subpopulations. Second, there are no
tandards available for ﬁbroblast densities and pre-conditioning
eriod, probably due to differences in dermal matrices and media
ormulations (presence or absence of serum and growth factors).
or instance, ﬁbroblasts proliferate better under serum-containing
onditions; and scaffold-based dermal constructs like nylon
eshes, collagen-glycosaminoglycan sponges or self-assembled
broblast sheets generally require longer pre-conditioning periods
n comparison to native ECM-based matrices like collagen or ﬁbrin.
uture research addressing methods to identify different ﬁbroblast
henotypes, their functional proﬁles, and establishing standards
or their use is pertinent for development of next generation of
kin equivalents.
Insights from wound healing in the fetus, oral mucosa and
iseased states provide us deeper understanding on the role of
broblasts and the surrounding microenvironment in reconstruc-
ing the lost dermal structures. In addition to the ﬁbroblasts, the
ole of stem cell populations like MSCs or adipose-derived stem
ells (AdSCs) in repair and regeneration is gaining importance.
urther, development in the stem cell ﬁeld has provided us with
pportunities to explore the potentials of pluripotent stem cells
hat include human embryonic stem cells (hESCs) and induced
luripotent stem cells (iPSCs). Adult stem cells (Chavez-Munoz
t al., 2013; Han et al., 2011; Lee et al., 2010; Tran et al., 2011)
nd pluripotent stem cells (Fu et al., 2010; Guenou et al., 2009;
ewitt et al., 2009; Kidwai et al., 2013; Metallo et al., 2008; Petrova
t al., 2014; Selekman et al., 2013; Tan et al., 2013) are known to
e capable of differentiation to various somatic lineages, including
broblasts and keratinocytes. Further, organotypic culture of the
broblasts and keratinocytes obtained from these stem cells have
een demonstrated to possess the ability to reconstruct the der-
is  and epidermis (Garzon et al., 2013; Guenou et al., 2009; Itoh
t al., 2013; Metallo et al., 2010; Petrova et al., 2014; Selekman
t al., 2013). Due to a primitive state of these stem cells and
he ability to coax their differentiation to ﬁbroblasts, it is plau-
ible to obtain different ﬁbroblast phenotypes by controlling the
ignals that drive their differentiation. Recently, Gnedeva et al.
2015) demonstrated the ability to drive the differentiation of
ESCs towards neural crest and further to dermal papilla cells that
pon implantation into immunodeﬁcient mice had the ability to
nduce hair formation. Similarly, it is plausible to differentiate these
tem cells to ﬁbroblasts that are phenotypically similar to fetal,
apillary or reticular dermal ﬁbroblasts. Second, it is also possible
o model diseased phenotypes like genodermatoses using pluripo-
ent stem cells as a source of skin cells. Furthermore, advances in
he stem cell ﬁeld opens up the potential to generate large num-
ers of donor-matched cells with the possibility of off-the-shelfell Biology 94 (2015) 483–512
availability that could potentially advance development of next
generation of skin equivalents. These next generation organotypic
skin equivalents are promising from a stand-point of basic research
and industrial purposes like cosmetic/chemical/pharmaceutical
product testing. However from a clinical standpoint, the use of
fetal-derived cells, hESCs and iPSCs are limited by safety (tumor
formation), histocompatibility, regulatory and ethical concerns.
The development of novel methods for generation and differ-
entiation of hESCs and iPSCs that address these limitations is
promising.
Certainly, a complex full-thickness in vitro skin model resem-
bles more closely human skin than simple monolayer cultures
or cocultures of individual cells. Hence, in vitro models to study
skin biology in health and disease have moved from simple mono-
layer cultures and cocultures to 3D organotypic skin equivalents.
These 3D skin equivalents composed traditionally of keratinocytes
and ﬁbroblasts is becoming increasingly more complex and more
close to native skin through incorporation of other skin cell types
including melanocytes (Cario-Andre et al., 2007; Duval et al., 2001),
Langerhans cells (Facy et al., 2004, 2005), endothelial cells (Chan
et al., 2012; Marino et al., 2014; Sanchez-Munoz et al., 2015),
and peripheral neurons (Blais et al., 2014). Further, addition of
other cell types including cells of the hair follicle and sweat glands
are currently in process. Similarly, the platform of organotypic
skin cultures is extended to model various diseased conditions
including psoriasis (Bernard et al., 2007, 2012; Jean et al., 2009),
vitiligo (Bessou et al., 1997; Cario-Andre et al., 2007), dermatitis
(Bernard et al., 2012; Gschwandtner et al., 2013; Kuchler et al.,
2011; Mildner et al., 2010; van den Bogaard et al., 2013), melanoma
(Li et al., 2010, 2011; Marrero and Heller, 2012; Vorsmann et al.,
2013), squamous cell carcinoma (Commandeur et al., 2012; Depner
et al., 2014), aging (Pageon, 2010; Pageon et al., 2007), photo aging
(Bernerd and Asselineau, 2008; Bernerd et al., 2012), pressure
ulcers (Bronneberg et al., 2006) and wounds (Egles et al., 2008;
El Ghalbzouri et al., 2004; Smithmyer et al., 2014; van Kilsdonk
et al., 2013). Recently, cosmetic giant L’Oreal has partnered with
3-D bio-printing company Organovo Holdings, Inc. to develop 3D
printed skin tissue for in vitro cosmetic product evaluation and
other advanced research applications. Furthermore, the platform
for in vitro skin cultures is moving ahead to incorporate these skin
cultures within microﬂuidic chips to develop skin-on-chip (Atac
et al., 2013) and multiorgan-on-chip (Wagner et al., 2013) models
(Fig. 6, Table 2).
In conclusion, the term ‘dermal ﬁbroblasts’ is an oversimpliﬁca-
tion of a dynamic, heterogeneous population of cells that exhibit
differences in terms of embryological origin, anatomical distri-
bution and functional proﬁles in health and disease. We  are just
beginning to understand the diversity of these ﬁbroblasts and their
roles in cell–cell and cell–matrix interactions that deﬁnes the struc-
ture and organization of the skin. We believe the insights learnt
from the diversity and physiology of the ﬁbroblasts in health and
diseased states could pave way in the generation of superior skin
equivalents.
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